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Background: Cognitive remediation is a behavioural intervention that aims to improve 
cognitive functioning with the goal of durability and generalisation.  Although evidence 
suggests that computer-assisted cognitive remediation (CACR) improves cognitive 
functioning in individuals with schizophrenia, it remains unclear whether these effects 
generalise and lead to improvements in clinical symptoms and psychosocial functioning.  
The current study aimed to investigate the effects of CACR on clinical symptoms, 
cognitive functioning and psychosocial functioning in individuals with schizophrenia or 
schizoaffective disorder. 
Method: A systematic review was performed using the quality assessment criteria 
defined by Scottish Intercollegiate Guidelines Network (SIGN 50) to investigate the 
effects of CACR on clinical symptoms in individuals with a diagnosis of schizophrenia 
or schizoaffective disorder.  Additionally, a within subjects repeated measures design 
was used to investigate the effects of CACR on cognitive functioning, functional 
capacity and everyday social functioning.    
Results: There was some evidence to suggest that CACR improves clinical symptoms, 
but the majority of studies reviewed did not report a significant effect, and a number of 
methodological weaknesses were identified in the literature.  Results of the experimental 
study revealed improvements in speed of processing, reasoning and problem solving and 
the overall composite score for cognition, but these improvements could not be 
attributed solely to the CACR intervention.  No improvements in functional capacity or 
everyday social functioning were observed.     
Conclusions: Further, more rigorous research is required to develop a clearer 
understanding of the effects of CACR on clinical symptoms.  The results of the 
experimental study support previous literature which has identified that a pure CACR 
intervention does not improve psychosocial functioning.  The results are discussed in 
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Background: Cognitive remediation has been found to improve cognitive functioning, 
psychosocial functioning and clinical symptoms, in individuals with schizophrenia 
(McGurk et al., 2007).  Recently, a review has demonstrated that computer-assisted 
cognitive remediation (CACR) improves cognitive functioning in individuals with 
schizophrenia (Grynszpan et al., 2011).   The literature evaluating the effects of CACR 
on clinical symptoms has not yet been subject to a systematic review.   
 
Method: A literature search was conducted to identify randomised controlled trials, 
investigating the effects of CACR on symptoms.  A systematic review was then 
performed using the quality assessment criteria defined by Scottish Intercollegiate 
Guidelines Network (SIGN 50).  Cohen’s d was used to calculate effect sizes for each 
study, to evaluate the effectiveness of CACR at improving clinical symptoms. 
 
Results: Fourteen studies met the inclusion criteria, and produced mixed results.  Four 
studies reported a significant effect of CACR on symptoms.  Eight studies, including the 
methodologically stronger studies, reported no significant effect on clinical symptoms.  
Clear conclusions were difficult to draw, due to a number of methodological weaknesses 
identified in the literature.    
 
Conclusions: While there was some evidence for the effectiveness of CACR, 
methodologically stronger studies reported minimum benefits.  Further studies that 
account for the methodological weaknesses of research in this area are needed in order 
to develop a clear evidence base about the effects of CACR on clinical symptoms. 
 
 





1.2.1   Schizophrenia 
Schizophrenia is a severe mental illness characterised by profound disruptions in 
thinking, language, experience of emotions and perception (WHO, 2012).  
Schizophrenia is thought to affect around 7 per 1000 individuals in the adult population, 
with the age of onset typically within the range of fifteen to thirty-five years of age 
(WHO, 2012).  Schizophrenia is a notable cause of disability in developed countries, 
and during 2004/2005 the estimated total cost of schizophrenia in England, was 6.7 
billion pounds (Mangalore & Knapp, 2007).  Therefore, treatments to alleviate 
symptoms of schizophrenia and reduce disability in this population are of great clinical 
interest and may reduce the associated economic impact.   
 
1.2.2  Clinical symptoms of schizophrenia 
In the last two decades the symptoms of schizophrenia have been categorised into two 
distinct forms.  Positive symptoms include delusions, hallucinations and disorganised 
speech, while negative symptoms include flattened affect, alogia, a loss of sense of 
pleasure, a loss of motivation and social withdrawal (Eaton et al., 1995).  Treatments for 
symptoms associated with a diagnosis of schizophrenia include pharmacological 
interventions including typical and atypical antipsychotics and psychosocial 
interventions including family therapy and Cognitive Behavioural Therapy (NICE, 




1.2.3  Cognitive deficits in schizophrenia 
There is now substantial evidence supporting the view that impairment in cognition is a 
core feature of schizophrenia, which is present prior to disease onset and independent of 
clinical symptoms (Gold, 2004).  Green et al. (2000) identified level of cognitive 
functioning as a greater predictor of outcome than clinical symptoms.   Nuechterlein et 
al. (2004) reviewed evidence in this area and found that impairments in speed of 
processing, attention/vigilance, working memory, verbal memory, visual memory, 
problem solving and social cognition were frequently found in individuals with 
schizophrenia.  
 
Research suggests that during the onset of symptoms, there is a period of notable decline 
in cognitive functioning, followed by a period of stabilisation (Medalia et al., 2009).  
Bilder et al. (2000) investigated cognitive functioning in patients with first-episode 
schizophrenia and found a large generalised deficit of 1.5 SD, compared to a healthy 
control group.  Further to this finding, Heaton et al. (2001) reported that the level of 
cognitive impairment in individuals with schizophrenia remained stable, despite changes 
in clinical state both over a short-term period (mean 1.6 years) and long-term period 
(mean five years).  These findings highlight that this population can have disabling 
cognitive deficits, which are pervasive and have a significant impact on both functioning 
and recovery. 
 
The well documented presence of cognitive deficits in schizophrenia has resulted in 
suggestions that cognitive function should be included in the DSM-V, as a treatment–
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relevant dimension, in order to highlight the importance of cognitive function in relation 
to functional status and clinical outcome (Barch & Keefe, 2010). 
 
1.2.4  What is cognitive remediation 
Wykes and Spaulding (2011) reported that a cognitive remediation experts’ workshop 
defined cognitive remediation therapy (CRT) for schizophrenia as “a behavioural-
training based intervention, that aims to improve cognitive processes (attention, 
memory, executive function, social cognition) with the goal of durability and 
generalisation” (p84).   Within research in this field, a number of terms including 
cognitive rehabilitation and cognitive training have been used interchangeably. For the 
purposes of this review the term cognitive remediation will be used exclusively.  Many 
forms of cognitive remediation have been developed and evaluated but there is a notable 
distinction between those that rely on non-computerised manual tasks, such as paper and 
pencil exercises, and those that are delivered in a more standardised manner via a 
computer training series.  
 
Computer-assisted cognitive remediation (CACR) may have several advantages over 
some of the non-computerised tasks, as it offers a standardised training method that can 
provide immediate feedback and adapt to the current level of functioning of participants.  
Grynspan (2010) highlighted that CACR provides objective recording of performance 
and the use of computers promotes the acquisition of new compensatory strategies.  
Additionally, CACR can be delivered in a group format with minimum facilitators, 
which may provide a cost-effective alternative to face-to-face appointments with health 
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professionals.  This approach may also be more appealing to patients who have 
difficulty engaging with health professionals.   
 
1.2.5  Links between cognitive deficits, symptoms and poor outcome  
In a meta-analysis of relevant literature, Green et al. (2000) identified associations 
between specific cognitive domains and functional outcome measures in individuals 
with schizophrenia.  More specifically, secondary memory was linked with all outcome 
measures, immediate memory was linked with skill acquisition, executive function was 
linked with community functioning and vigilance was linked to skill performance 
(Green et al., 2000).  Further studies have linked cognitive impairments to work 
performance (Bell et al., 2001), everyday functioning capacity (Twamley et al., 2002) 
and quality of life (Mohamed et al., 2008).   These findings support the view that 
interventions aimed at improving cognitive functioning may in turn improve 
psychosocial functioning in individuals with schizophrenia. 
 
Mohamed et al. (2008) highlighted that clinical symptoms, particularly positive 
symptoms, were related to quality of life.  Additionally, Hunter and Barry (2011) found 
that negative symptoms showed strong and significant correlations with daily 
functioning, as assessed across a number of psychosocial outcome measures.  This 
finding was supported by a literature review conducted by Green (1996), which reported 
that negative symptoms showed consistent associations with social problem solving and 
some weaker associations with community functioning.  This evidence suggests that a 
greater severity of clinical symptoms is associated with poorer outcomes on numerous 
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assessments of psychosocial functioning; therefore, interventions that aim to reduce 
symptoms may also improve psychosocial functioning in individuals with 
schizophrenia. 
 
Due to the demonstrated links between cognitive functioning, clinical symptoms and 
psychosocial functioning, it is of interest to develop the knowledge base regarding the 
effects of CACR on these three factors.  In order to improve future treatments for 
individuals with schizophrenia, it is of particular interest to investigate whether a 
treatment that aims to improve cognitive functioning has any additional effects on 
symptoms and functioning. 
 
1.2.6  Why do this review? 
A number of reviews have evaluated the effects of cognitive remediation (Kurtz et al. 
2001; Pilling et al. 2002; Krabbendam & Aleman, 2003; Twamley et al. 2003; McGurk 
et al. 2007).  There is a growing body of literature supporting the use of cognitive 
remediation techniques to improve cognitive functioning in individuals with 
schizophrenia.  McGurk et al. (2007) reported that cognitive remediation had a medium 
effect (0.41) for overall cognition, a small to medium effect (0.35) for functioning and a 
small effect (0.28) for symptoms.  Cognitive remediation has also been found to have a 
greater effect on psychosocial functioning when offered in addition to psychiatric 
rehabilitation (McGurk et al., 2007).  Although this review provided promising findings 
to support the use of cognitive remediation, its analysis did not distinguish between 
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computer-assisted methods and more traditional techniques; therefore, no conclusions 
could be drawn about the comparative effectiveness of each method of delivery.   
 
As previously discussed, CACR may have several advantages over some of the non 
computerised approaches, as it provides a standardised training method that can give 
immediate feedback and adapt to the current level of functioning of the participant.  
Grynszpan et al. (2011) reported results in line with previous reviews of cognitive 
remediation; reporting that CACR had an effect size of 0.38 on general cognition.  
Additionally, this study found that interventions targeting specific cognitive domains did 
not produce higher effects than those using non-domain specific interventions 
(Grynszpan et al., 2011).  Although this provided evidence to support the use of CACR 
to improve cognitive functioning in individuals with schizophrenia, it did not evaluate 
the effects of CACR on symptoms or psychosocial functioning.  A growing body of 
literature has investigated the effects of CACR on clinical symptoms, but to date this 
literature has not been reviewed and therefore it remains unclear whether CACR can 
improve clinical symptoms. 
 
McGurk et al. (2007) conducted a review of controlled studies evaluating the effects of 
cognitive remediation on clinical symptoms in individuals with a diagnosis of 
schizophrenia or schizoaffective disorder. This study found that cognitive remediation 
had a small effect on clinical symptoms, therefore, it was hypothesised that CACR 




1.3  Method 
The review was conducted in a manner consistent with the guidance for undertaking 
systematic reviews set out by the Centre for Reviews and Dissemination (2009).  These 
guidelines are internationally recognised, and are recommended by the National Institute 
for Health and Clinical Excellence (NICE).  In the current review, the effects of CACR 
on clinical symptoms were established by calculating effect sizes across time of the 
differences between the CACR and control groups.   
 
1.3.1  Procedure 
Prior to undertaking the systematic review, a literature search was undertaken to identify 
previous reviews of CACR in schizophrenia.  The Cochrane Database of Systematic 
Reviews (CDSR) and the Database of Abstracts and of Reviews of Effects (DARE) 
were searched, in addition to a wider search of online databases.  This process identified 
one systematic review, conducted by Grynszpan et al. (2010), relevant to the research 
topic.  Grynszpan et al. (2010) evaluated the efficacy of CACR in relation to associated 
effects on cognitive functioning, but did not evaluate any effects on other factors such as 
clinical symptoms or psychosocial functioning.  It was therefore identified that a 
systematic review evaluating the efficacy of CACR on either of these outcome measures 
would be a beneficial addition to the existing literature. 
 
1.3.2  Literature search procedure 




language articles that were published in peer-reviewed journals in four online databases.  
The following electronic databases were searched up to the end of February 2012: 
 PsychINFO (from 1990) 
 MEDLINE (from 1946) 
 Embase (from 1980) 
 CINAHL (from 1937) 
 
The literature search combined the following keywords: ‘schizophrenia’ or 
‘schizoaffective disorder’ AND ‘cognitive training’ or ‘attention training’ or ‘cognitive 
remediation’ or ‘cognitive rehabilitation’ AND ‘computer-assisted’.  The reference list 
of each selected article was then scanned to identify any additional articles.  Table 1.1 
provides a summary of results obtained from all sources.  The literature search produced 
371 potential papers, 14 of which were included in the current review.  A detailed 
breakdown of the literature search procedure can be seen in Figure 1.1. 
 
1.3.3  Inclusion and exclusion criteria 
Studies that met the following criteria were included in the current systematic review:  
1) A randomised controlled trial investigating the benefits of CACR using a pre/post 
design. 
2) A pre/post assessment of clinical symptoms using at least one standardised measure. 
3) A sample that consisted of adult participants, exclusively with a diagnosis of either 




In summary, studies were eligible for inclusion if they were randomised controlled 
trials, investigating the effects of CACR in an adult population with a diagnosis of 
schizophrenia or schizoaffective disorder, using a pre and post-design that included at 
least one validated outcome measure of clinical symptoms. 
 











1.3.4  Population 
The studies included in the review were based exclusively on adult participants with a 
diagnosis of either schizophrenia or schizoaffective disorder.     
 
1.3.5  Intervention 
Because of the limited number of clinical symptoms outcome studies in this area, all 
studies that used CACR were considered for the current review. The studies included in 
the review used a variety of interventions; some relied on a pure CACR intervention 
while others used CACR as part of a wider intervention. 
Source of articles Number of potential 
articles 













All sources 371 
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1.3.6  Comparators 
Studies were eligible for inclusion if they compared a form of CACR (either a pure 
CACR intervention or CACR as part of the intervention) to either a treatment as usual 
Excluded after screening 
titles/abstracts  
n = 317 
 
Excluded after screening n = 40 
 Data not available 
 n = 1 
 Duplicate data   
n = 3 
 Mixed population  
n = 2 
 No control group  
n = 4 
 No post assessment  
n = 3 
 Not CACR  
n = 6 
 Not randomised  
n = 1 
 Review paper  
n = 3 
 Study protocol  
n = 1 
 Symptoms not assessed 
n = 16 
 
Provisionally 
included studies  
n = 54 
 
Initial studies 
screened for inclusion 
n = 371 
 
Number of studies 
included in the review  




condition (TAU), active control condition (e.g. computer games) or passive control 
condition (e.g. waiting list control). 
 
1.3.7  Outcome measures 
Studies assessing clinical symptoms pre and post-intervention through validated self 
report and/or observer rated measures were included in the current review.  Where the 
pre and post-assessment scores were not reported in the article the authors were 
contacted requesting this data.   
 
1.3.8  Statistics 
Cohen’s d values measuring the effect sizes between CACR and control conditions were 
calculated using the means and standard deviations of symptom outcome measures 
reported in the papers.  Where this data was not reported, the authors were contacted 
requesting this information.  Morris (2008) evaluated methods for establishing effect 
sizes in pre-post test designs and concluded that the effect size should be calculated 
using both the pre-test and post-test information in order to take full advantage of all the 
information available.  Morris (2008) recommended using the mean change from pre-
test to post-test in the experimental and control group, divided by the pooled pre-test 
standard deviation.  This method was employed in the current review and for each study 




1.3.9  Assessment of quality of included studies 
The quality of the studies included in the current review was evaluated using the 
Scottish Intercollegiate Guidance Network (SIGN) methodology checklist for 
randomised controlled trials.  Each study was rated and scored on the 10 quality criteria 
using the outcome ratings recommended by SIGN: ‘well covered’ (2); ‘adequately 
addressed’ (1); and ‘poorly addressed’, ‘not reported’ and ‘not applicable’ (all 0), to 
allow an overall comparison between studies.  A detailed breakdown of the scoring 
criteria used in the current review can be found in appendix 2.  Five of the studies 
included in the current review were independently rated by S.O on the 10 quality 
assessment criteria to ensure consistency in the ratings.  The reviewers (J.M & S.O) 
found agreement on 78 per cent of the quality assessment criteria. Where differences 
were found, these were reviewed and amended appropriately. 
  
1.4 Results 
From the 371 studies identified by the original literature search, 317 were excluded after 
screening the titles and abstracts, as they did not meet the inclusion criteria for the 
current review.  A further 40 articles were excluded after a more detailed screening of 
the articles was undertaken (appendix 3).  A total of 14 studies, comprised of 983 
participants, met the inclusion criteria for the current review.  The outcome measure 
scores from a total of four studies (Cavallaro et al., 2009; Hogarty et al., 2004; Hodge, 
2010; Galderisi, 2010) were not available and therefore effect sizes were calculated for 
the remaining 10 studies.  The characteristics of the included studies, a summary of the 
main findings and their associated effect sizes can be seen in Table 1.2.    
23 
 
Table 1.2.        Characteristics, main findings and effect sizes of reviewed studies 
  Sample Characteristics      







Summary of relevant 
results 














None 2 half hour 
sessions per 




The CACR group 
demonstrated 
significantly greater 
reduction from pre to 
post test scores on 3 of 
5 SANS subscales and 
the global SANS score.   
SANS summary  
d = 0.70 
SANS subtests  
d = 0.24 - 0.66 



















None 3 1-hour 
sessions per 
week for 12 
weeks (total of 
36 hours) 
PANSS Clinical symptoms 
remained unchanged 
between the two 
groups throughout all 
the observations 
Data not available 
 
 










None 14 2-hour 




No improvements in 
positive or negative 
symptoms as 
measured by the 
PANSS or the CGI 
PANSS Positive  
d =  0.06 
PANSS Negative  
d = -0.25 
PANSS General  
















3 per week for 
15 weeks 




No significant effects 
on any symptom 
outcome measure post 
or follow up. 
 BPRS   
d = -0.19 
SANS   
d = -0.10 
 





































CACR had significant 




compared to EST 
Symptoms year 1  
d =  0.55 
Symptoms  year 2  




         


































No significant effect on 
symptoms at year 1 or 
2 
Data not available 
 












None 2 45 minute 
sessions per 





improvement in PANSS 
scores in CACR group 
compared to control 
CGI-S  
d =  0.53 
PANSS positive  
d = 0.58 
PANSS negative  
d = 0.64 
PANSS total  
d = 0.85 














None 2 45 minute 
sessions per 
week (12 in 
total) 
PANSS Effects on clinical 
symptoms not reported 
in analyses 
PANSS negative  
d = 0.09 
PANSS positive  
d = 0.10 
PANSS total  
d = 0.16 
 



















PANSS No significant 
interaction of condition 
or time and no 
significant main effect 
of condition or time on 
PANSS scores 
PANSS positive  
d = -0.07 
PANSS negative  
d = -0.12 
PANSS total  








Ns not specified 





2 1-hour session 
per week for 10-
15 weeks (20-30 




No significant change 
in PANSS or CDS 
scores from baseline to 
post treatment or at 4-
month follow up 
Unable to compute 
(scores not reported 
separately). 
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Note: - BPRS: Brief psychiatric rating scale; CACR: Computer assisted cognitive remediation; CDS: Calgary depression scale; GCI: 
Clinical global impression; CGI-S: Clinical global impression severity; GAS: Global Assessment Scale; IPT: Integrated Psychological 
Therapy; NEAR: Neuropsychological Educational Approach to Remediation; ORM: The Orientation Remedial Module; PANSS; positive 
and negative symptoms scale; SAPS: Scale for the assessment of positive symptoms; SANS; Scale for the assessment of negative 
symptoms;  SES: Self-esteem scale; SHAPS-D: German version of the Snaith-Hamilton Pleasure Scale. TAU; Treatment as usual; 
TSSN: Training of self-management skills for negative symptoms.  










None 15 sessions 
over 3-4 weeks 
BPRS 
GAS 
PD scale of von 
Zerssen 
Improvements in 
symptoms in all 3 




 d = -0.12, BPRS 
anergia d = -0.13,  
BPRS thought 
disturbances  
d = 0.18, BPRS 
activation d = 0.30, 
BPRS hostility 
 d = 0.55, PD-S 
hostility d = 0.19 
PD-S depression  










None 18 sessions 
over 6 weeks 
BPRS Both groups showed 
significant change on 
BPRS, but CACR 
group improved 
significantly more 
BPRS   
d = 0.27 
 













 2 90-minute 
sessions twice a 






difference was found 
for TSSN in 
improvements of 
negative symptoms 
PANSS negative  






















None 2 1-hour 
sessions per 





No interaction time x 
group x clinical 
symptoms dimension x 
group was observed. 
Data not available 
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1.4.1 Quality of included studies 
Table 1.3 provides ratings for each of the 14 studies on the SIGN quality criteria, which 
offers a guide to the studies’ methodological strengths and weaknesses.  It indicates that 
Dickinson et al. (2010) conducted the strongest study methodologically, while Hogarty 
et al. (2004) and Hermanutz & Gestrich (1991) carried out the weakest.  There was 
variation in the control conditions used across the studies.  Of the studies included in the 
current review, nine used an active control condition such as computer work (Cavallaro 
et al., 2009; Dickinson et al., 2010; Fisher et al., 2010); enriched supportive therapy 
(Eack, 2009; Hogarty et al., 2004); psychosocial intervention (Vita et al. , 2011); nature 
documentaries (Medalia, 1998); vocational rehabilitation (Vauth, 2005) or structured 
leisure activities (Galderisi, 2010).  The remaining five studies used a passive control 
condition such as a waiting list control (Belluci et al., 2003; D’Amato et al., 2011; 
Hodge, 2010) or treatment as usual (Wolwer et al., 2005; Hermanutz & Gestrich, 1991). 
 
All studies included in the current review were scored as having an ‘adequately 
addressed’ or ‘well covered’ focused question relating to their research.  It should be 
noted that the effect of CACR on symptoms was frequently not one of the primary 
research questions and one study (Wolwer et al., 2005) did not discuss any effects on 
symptoms, however, it included sufficient data to be included in the current review.  All 
studies included in the current review used some form of randomisation in their 
methodology.  Five studies gave detailed descriptions of their method of randomisation 
(Dickinson et al., 2010; Eack, 2009; Hogarty et al., 2004; Vita et al., 2011; Hodge, 2010) 
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while the remaining nine studies simply stated that participants were randomised to 
conditions. 
 
Only four studies explicitly used some form of adequate concealment at the start of their 
study (d’Amato et al., 2011; Fisher et al., 2010; Hodge, 2010 and Galderisi, 2010).  The 
remaining nine studies did not provide sufficient information to assess whether the 
researchers were unaware of participant group allocation at the time they entered the 
study.  Further to this, only five studies ensured assessors were fully blind to the 
participant group allocation when conducting the outcome assessments (D’Amato et al., 
2011; Vita et al., 2011; Fisher et al., 2010; Vauth, 2005 and Galderisi, 2010) and only 
one study (Belluci et al., 2002) ensured that participants were blind to their treatment 
group throughout the study.    
 
All studies included in the review considered whether the groups were similar at the start 
of their research and were scored ‘well covered’ or ‘adequately addressed’ on this 
quality criterion.  Two papers (Belluci et al., 2003 and Dickinson et al., 2010) stated that 
the treatment under investigation was the only difference between groups.  It was 
unclear in a further two papers (Eack, 2009 and Hogarty et al., 2004) whether the 
treatment was the only difference.  In the remaining ten studies it seemed likely that the 
treatment was the only difference, however, this was not explicitly stated. 
 
Five studies used robust outcome measures that are intended for use with this population 
(Cavallaro et al., 2009; d’Amato et al., 2011; Eack, 2009; Hogarty et al., 2004 and 
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Fisher et al., 2010); the remaining studies all used standardised measures that were not 
designed specifically for use with this population.  Four studies failed to include 
sufficient information about dropout rates in their papers (Belluci et al., 2003; d’Amato 
et al., 2011; Eack, 2009 and Hermanutz & Gestrich, 1991).   
 
Only three studies included in this review clearly stated that intention to treat analyses 
were carried out (Dickinson et al., 2010; Eack, 2009 and Wolwer et al., 2005).  Although 
many of the studies are likely to have conducted intention to treat analyses, it was not 
clearly stated in the papers. 
 
1.4.2  Effects on symptoms 
When effect sizes were not reported for symptom outcome measures for the intervention 
and control groups, they were calculated using Cohen’s d.  The effects of CACR on 
clinical symptoms varied considerably across studies.  Of the papers included in the 
current review, only one study used an intention to treat analysis (Eack, 2009).  Four 
studies reported that compared to the control condition, CACR had a significant effect 
on clinical symptoms as assessed by a standardised measure (Belluci et al., 2003; Eack, 
2009; Vita et al., 2011; Medalia, 1998).  Belluci et al. (2003) reported that CACR was 
found to significantly reduce scores on the Scale for the Assessment of Negative 
Symptoms (SANS) on three of the five subscales as well as the SANS total score.  
Belluci et al. (2003) noted that CACR resulted in small to medium effect sizes on the 
SANS subscales and total score (d = 0.24 – 0.70).  Eack (2009) reported that compared 
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to enriched supportive therapy, CACR significantly improved symptoms as defined as a 
composite score, with a medium effect at year 1 (d= 0.55) and a large effect at year 2 
(d= 0.82).  Vita et al. (2011) reported that compared to a psychosocial intervention, 
CACR significantly improved symptoms with a medium effect (d = 0.53) as assessed by 
the Clinical Global Impression-Severity (CGI-S) scale and with medium to large effects 
(d = 0.58 – 0.85) as assessed by the Positive and Negative Syndrome Scale (PANSS).   
Medalia (1998) reported that CACR significantly improved symptoms, as assessed by 
the Brief Psychiatric Rating Scale (BPRS), with a small effect (d= 0.27).   
 
Eight studies, including the four with the highest quality assessment rating scores, 
reported that CACR did not have a significant effect in comparison to control conditions 
on clinical symptoms (Cavallaro et al., 2009; d’Amato et al., 2011; Dickinson et al., 
2010; Hogarty et al., 2004; Fisher et al., 2010; Hermanutz & Gestrich, 1991; Hodge, 
2010; Galderisi, 2010).  It is worth noting that Hermanutz & Gestrich (1991) found 
improvements in symptoms in all three groups in their study, but the CACR group had 
associated small to medium effects on symptoms as assessed by the BPRS, GAS and the 
von Zerssen scale. 
 
A further two studies did not report the effects of CACR on symptoms, however, they 
provided sufficient information about symptom outcome measure scores, to be included 
in this review (Wolwer et al., 2005; Vauth, 2005).  When Cohen’s d effect sizes were 
calculated for these studies, mixed results were obtained.  The study by Wolwer et al. 
(2005) resulted in effect sizes ranging from 0.09 for the PANSS negative subscale, 0.10 
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for the PANSS positive subscale and 0.16 for the PANSS total score.  These findings 
indicate that CACR did not have a clinically meaningful effect on clinical symptoms.  
 
Vauth (2005) investigated the effects of a comparison group on clinical symptoms, but 
did not investigate the effects of CACR on the clinical symptoms outcome measures.  
Vauth’s (2005) study resulted in effect sizes ranging from -0.41 for the PANSS negative 
subscale to 0.54 for the German version of the Snaith Hamilton Pleasure Scale (SHAPS-
D) anticipatory anhedonia subscale.  These findings provide some evidence that CACR 




Table 1.3: Quality assessment criteria as defined by SIGN-50 guidelines 





















































































































































































































































































































Note: WC: well covered, AA: adequately addressed, PA: poorly addressed, NA: not addressed, NR: not reported, N/A: not applicable. 
Quality criteria 
1.1)  The study addresses an appropriate and clearly focused question.  
1.2)  The assignment of subjects to treatment groups is randomised. 
1.3)  An adequate concealment method is used. 
1.4)  Subjects and investigators are kept ‘blind’ about treatment allocation. 
1.5)  The treatment and control groups are similar at the start of the trial. 
1.6)  The only difference between groups is the treatment under investigation. 
1.7)  All relevant outcomes are measured in a standard, valid and reliable way. 
1.8)  What percentage of the individuals or clusters recruited into each treatment arm of the study dropped out? 
1.9)  All the subjects are analysed in the groups to which they were randomly allocated (often referred to as intention to treat 
         analysis).  
1.10)  Where the study is carried out at more than one site, results are comparable for all sites 
 
 












































































































Total scores 25 18 
 






1.5  Discussion 
The current systematic review aimed to review previous research to evaluate the 
effectiveness of CACR in improving clinical symptoms in individuals with a 
diagnosis of schizophrenia or schizoaffective disorder.  There were differences in the 
methodologies of the studies included in the current review.  The majority of the 
studies reviewed failed to report whether an adequate form of concealment was used 
in their study.  In addition to this, most studies were weakened by their failure to 
ensure that assessors and participants were blind to group allocation.  Such 
weaknesses in the research need to be addressed and there is a need for further, more 
rigorous research, which uses adequate concealment and employs appropriate 
blinding techniques.   
 
There were inherent differences in interventions offered both as treatment and 
control conditions by the studies included in the current review.  This resulted in the 
interpretation of results being somewhat difficult.  Some studies made use of an 
active control condition, whilst others made use of a passive control condition.  
Additionally, some studies used CACR as part of a wider intervention, while other 
studies used a pure form of CACR as the sole intervention.  Although it would have 
been beneficial to conduct a review investigating the effects on symptoms of either a 
pure CACR intervention or the use of CACR as part of a wider intervention, the 
limited number of studies in this area meant it was not feasible and both intervention 







Of the fourteen papers included in the current review, four reported a significant 
effect of CACR on clinical symptoms, as assessed by a standardised measure.  These 
four studies were of similar quality as assessed by the quality criteria, but it is worth 
noting that a number of studies that were deemed to be stronger methodologically did 
not report a significant effect of CACR on clinical symptoms.     
 
Three of the four studies that reported significant effects of CACR on clinical 
symptoms offered a pure CACR intervention.  Additionally, the studies that found 
significant effects all used measures developed for specific use with this population.  
However, it is also worth noting that the same measures were employed in some of 
the studies that did not report an effect, but were considered stronger 
methodologically.  Five of the eight studies (Fisher et al., 2009; Hermanutz & 
Gestrich, 1991; Dickinson et al., 2010; Cavallaro et al., 2009; D’Amato et al., 2011) 
that did not report a significant effect of CACR on clinical symptoms offered a pure 
CACR intervention programme. 
 
The results of this review do not provide enough evidence to conclude that CACR 
has a specific effect on clinical symptoms.  Although four studies reported significant 
effects of CACR on clinical symptoms (ranging from small to large effect sizes), 








1.5.1  Strengths of the review 
The current article aimed to review an area of clinical importance and to answer a 
question that has not been reviewed previously.  Additionally, the current systematic 
review also aimed to be as pure as possible, by excluding studies that included 
individuals with diagnoses other than schizophrenia or schizoaffective disorder.  
Where necessary data was not available from journal articles, primary and secondary 
authors were contacted to request this data.  A high level of inter-rater reliability was 
found in the journal articles, which were reviewed by two independent people (J.M 
& S.O), suggesting consistency of the quality criterion ratings.  
 
1.5.2  Limitations of the review 
Due to a lack of translation resources, the current systematic review was limited to 
articles published in English and it was acknowledged that a number of German 
articles may have been eligible for inclusion.  Despite a growing interest over recent 
years in the effects of CACR, the relatively small numbers of studies investigating 
the effects of CACR on clinical symptoms resulted in studies with a variety of 
treatments and measures being included in the current review.  As more research is 
published in this area, it would be beneficial to conduct a further review, drawing 
comparisons between studies that used a pure CACR intervention and those that used 
CACR as part of a wider intervention.   
 
1.5.3  Implications for clinical work and future research 
Although there is strong evidence demonstrating the clinically beneficial effect of 






insufficient evidence to conclude that CACR is effective at improving clinical 
symptoms in individuals with a diagnosis of schizophrenia or schizoaffective 
disorder, and that additional treatments will need to be considered to improve clinical 
symptoms in this population.  
 
One of the main goals of offering CACR is the hope that any effect will generalise to 
psychosocial functioning and thereby, reduce disability and improve quality of life in 
this population.  A number of studies have investigated the effects of CACR on 
psychosocial functioning and a comprehensive review of this area of interest would 
be beneficial.  Additional studies further investigating the benefits of CACR on 
cognitive functioning, psychosocial functioning and clinical symptoms are required 
to expand the knowledge base in this field and develop a clearer understanding about 
the efficacy of CACR. 
 
1.6  Conclusions 
This systematic review of the effects of CACR on clinical symptoms, in individuals 
with a diagnosis of schizophrenia or schizoaffective disorder found insufficient 
evidence to draw firm conclusions about an effect.  While a number of papers did 
demonstrate small to large effects of CACR on clinical symptoms (d = 0.25 – 0.82), 
the methodologically stronger papers did not report a significant effect.  It should be 
noted that the majority of papers in this area had a number of key weaknesses that 
should be addressed by future research.  Future research needs to be rigorous and 







1 Ensuring an adequate concealment method is employed to ensure researchers are 
not aware of participant group allocation at the start of the research. 
2 Employing a double blind design where possible, or ensuring that at least the 
assessors are blind to participant group allocation. 
3 Ensuring that control groups are well matched in order to certify that the 
treatment is the only difference between groups and control for non-treatment 
effects such as frequency of contact. 
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CHAPTER 2: INTRODUCTION 
  
2.1  Effects of CACR on cognitive functioning 
To date, only one review has evaluated the effects of CACR on cognitive functioning 
in individuals with a diagnosis of either schizophrenia or schizoaffective disorder.  
Grynszpan et al. (2011) found results in line with previous reviews of cognitive 
remediation reviews, and reported that CACR had an effect size of 0.38 on general 
cognition.  Although this meta-analysis, of sixteen randomised controlled trials 
provided substantial evidence supporting the efficacy of CACR, a number of 
negative reports have also been published.  Murthy et al. (2012) investigated the 
effects of CACR on cognitive functioning and functional capacity in individuals with 
schizophrenia, in a multi-site clinical trial involving fifty-five participants.  Murthy et 
al. (2012) found that participants improved on the training tasks but this effect did 
not generalise to independent measures of cognitive functioning or functional 
capacity.  This study used a CACR intervention that aimed to train only auditory 
information processing; this limitation may account for the lack of findings.  
 
Dickinson et al. (2010) also conducted a randomised controlled trial investigating the 
benefits of cognitive remediation on cognitive functioning and functional outcome in 
schizophrenia.  Similar to Murthy et al. (2012), this study found participants’ 
performance improved on the training tasks, but these improvements did not 
generalise to performance on neuropsychological tests or assessments of 
psychosocial functioning.  Dickinson et al. (2010) developed a cognitive remediation 






that had been used in previous research and had an established evidence base.  These 
reports of negative results highlight the need for further investigations into the key 
components of successful cognitive remediation to inform future treatments. 
 
Studies investigating the effects of CACR vary in the software used, the tasks 
completed, and the duration or intensity of the intervention.  One component that is 
of particular interest is the minimum dose of intervention required to improve 
cognitive functioning.  Field (1997) reported that a three week intervention 
consisting of two sessions per week was not effective at significantly improving 
attention in individuals with a diagnosis of schizophrenia.  
 
However, Hermanutz & Gestrich (1991) reported that a four week CACR 
intervention that consisted of four sessions per week was effective at improving 
attention in individuals with a diagnosis of schizophrenia, but did not improve ratings 
of social, occupational and psychological functioning as assessed by the Global 
Assessment Scale (GAS).  Similarly, Medalia, Revheim & Casey (2001) reported 
that a five week intervention, consisting of two sessions per week, significantly 
improved problem solving skills in individuals with a diagnosis of schizophrenia.  
Further evidence in support of a brief CACR intervention was provided by Bellucci 
et al. (2002) who found that an eight week CACR intervention consisting of two 
sessions per week significantly improved verbal memory and attention in individuals 







The mixed results from studies investigating the benefits of CACR, suggest that 
further research is needed to evaluate the efficacy of brief CACR interventions.  The 
studies that have previously investigated brief CACR interventions have a number of 
weaknesses.  More specifically, only one of the studies discussed above investigated 
whether any effects of CACR generalised to psychosocial functioning, despite this 
being one of the main goals of CACR.  Additionally, these studies did not include 
any form of follow-up to investigate whether the effects of a brief CACR 
intervention were sustained.   
   
2.2  Effects of CACR on psychosocial functioning 
Although there is growing evidence that CACR is effective at improving cognitive 
functioning in individuals with schizophrenia, there are mixed results regarding 
whether these benefits generalise to psychosocial functioning.  
 
Hogarty (2004) compared the effects of cognitive enhancement therapy with 
enriched supportive therapy, on cognitive functioning and behavioural outcome 
measures.  This study found that cognitive enhancement therapy had a greater effect 
than enriched supportive therapy on social adjustment, at both the 12 and 24-month 
follow-up periods.  This study indicates that the effects of CACR may generalise to 
social functioning in patients with a diagnosis of schizophrenia and that these effects 
are durable and last for up to 2-years post-intervention.  A further study conducted by 
Vita et al. (2010), which employed an RCT design involving seventy-two 






psychosocial functioning as assessed by the Health of the Nation Outcome Scale 
(HoNOS).   
 
Cavallaro et al. (2009) evaluated a three month cognitive remediation intervention in 
addition to a standard rehabilitation programme, and reported that patients in the 
CACR group had better outcomes as assessed by the Quality of Life Scale (QLS).  
This study provided encouraging results that CACR can have a positive impact on 
psychosocial functioning, as well as improving cognitive functioning.   
 
In addition to the above research, Poletti et al. (2010) reported that using CACR, in 
addition to a standard rehabilitation treatment, had a significant effect over placebo 
training and standard rehabilitation treatment, on quality of life at post- intervention.  
Interestingly, the improvement was seen to increase progressively at the 6 and 12-
month follow-up in the experimental group, suggesting that the effect continued to 
increase over time after the intervention had been stopped (Poletti et al., 2010).  
  
In addition to the encouraging results on quality of life, a growing number of articles 
have investigated the benefits of CACR on vocational outcome measures such as 
employment status, hours worked and money earned (Bell et al., 2005; Bell et al., 
2008; Vauth et al., 2005; McGurk et al., 2009).  A study investigating the benefits of 
CACR, (Bell et al., 2005; Bell et al., 2008) found that individuals who received 
neurocognitive enhancement therapy and work therapy, worked more hours and 
received better rates of pay than those who received work therapy alone, at both 6 






who received 24-hours of CACR, worked more weeks than a computerised control 
group over the 12-month follow-up period.   
 
Similar findings were reported by Vauth et al. (2005) who found that individuals 
who received CACR plus vocational rehabilitation, were more likely to be in a job 
placement at 12-month follow-up than those who received training for the self 
management of negative symptoms and vocational rehabilitation, or vocational 
rehabilitation alone.  Further analyses of the results of this study identified that 
improvement in verbal memory was a greater predictor of successful job placement 
than pre-treatment history of employment (Vauth et al., 2005).  This study identified 
that verbal memory may be a key target for vocational interventions aiming to 
improve functioning in employment.   
 
Further research into the benefits of CACR on vocational outcome measures was 
conducted by McGurk et al. (2009) who reported better work outcomes over the 2 
year follow-up period for individuals who received CACR and vocational 
rehabilitation than those who received vocational rehabilitation alone.  Research into 
the use of CACR alongside vocational rehabilitation suggests that CACR has a 
positive effect when used in combination with other forms of rehabilitation seeking 
to improve occupational functioning.   
 
Despite a growing number of papers reporting that CACR has a positive effect on 
various measures of psychosocial functioning, a number of papers have also 






in addition to standard treatment in individuals with a diagnosis of schizophrenia.  
d’Amato et al. (2010) reported that CACR had significant effects on a number of 
cognitive functions but no effect on measures of social autonomy or quality of life.  
An additional study conducted by Hermanutz & Gestrich (1991) evaluated the effects 
of CACR on clinicians’ ratings of social, occupational and psychological functioning 
as assessed by the Global Assessment Scale (GAS).  This study found no significant 
difference between groups on overall GAS scores across time, suggesting that CACR 
did not improve functioning as assessed by The GAS.   
 
2.3  Rationale for the current research 
The literature investigating the effects of CACR on cognitive functioning and 
psychosocial functioning has produced mixed results and there is a need for further 
research in this field to expand the existing evidence base.  Previous research 
investigating the effects of brief CACR interventions has produced both positive and 
negative results; therefore, there is a need for brief CACR intervention studies that 
investigate whether any effects of CACR on cognitive functioning are maintained 
across time and whether effects generalise to psychosocial functioning.  
 
A recent report from the Working Group Conference on Multi-Site Trial Design for 
Cognitive Remediation in Schizophrenia (Keefe et al., 2011) highlighted that 
psychosocial functioning is influenced by a number of factors and that a measure of 
functional capacity, such as the University of California in San Diego Performance-
Based Skills Assessment-Brief (Patterson et al., 2001) should be included in studies 







Clinically, it is of great interest to investigate whether a brief CACR intervention can 
improve cognitive functioning and psychosocial functioning in patients with a 
diagnosis of schizophrenia. 
 
2.4  Aims/Hypotheses 
2.4.1  Aims 
The aim of the current thesis is to conduct an experimental study to investigate the 
effects of a brief CACR intervention on cognitive functioning, functional capacity 
and everyday social functioning in individuals with a diagnosis of schizophrenia or 
schizoaffective disorder.  The research was considered to add to the previous 
literature by using a superior measure of cognitive functioning recommended for use 
in clinical trials.  Recent recommendations also highlight the need for cognitive 
remediation research to include a measure of functional capacity.  The current study 
included a recommended measure of functional capacity to investigate any effects of 
CACR.  Finally, the notable deficits in social functioning observed in this population 
resulted in a measure of social functioning being included to explore any potential 







2.4.2  Hypotheses 
After reviewing the selected literature the following hypotheses were proposed: 
 
1. A five week CACR intervention, consisting of two sessions per week, will 
improve cognitive functioning as assessed by the NIMH Measurement and 
Treatment Research to Improve Cognition in Schizophrenia (MATRICS) 
Consensus Cognitive Battery (MCCB).   
 
2. A five week CACR intervention, consisting of two sessions per week, will 
improve functional capacity as measured by the University of California in 
San Diego (UCSD) Performance Based Skills Assessment-brief (UPSA-
brief).   
 
3. A five week CACR intervention, consisting of two sessions per week, will 
improve social functioning as measured by three subtests of the Social 







CHAPTER 3: METHODOLOGY 
3.1  Design 
The study employed a repeated measures within-subjects design, with participants 
acting as their own controls.  In order to investigate the effects of a computer-assisted 
cognitive remediation (CACR) intervention on cognitive functioning, functional 
capacity and everyday social functioning, participants completed the outcome 
measures at four time points throughout the study.  The baseline assessment and the 
pre-intervention assessment served as the control for the current study.  All 
participants were followed up one-month post-intervention to investigate the 
durability of any observed gains.  Variables measured included cognitive functioning 
across seven cognitive domains, functional capacity and social functioning. 
 
3.2  Power Analysis 
G*Power version 3 is a power analysis programme for statistical tests commonly 
used in social and behavioural research (Faul, Erdfelder & Buchner, 2007).  The 
sample size for the current project was determined through a-priori power calculation 
using G*Power version 3.  A review of the previous literature was conducted to 
establish an appropriate effect size that could be used to determine the required 
sample size for the current study.   McGurk et al. (2007) conducted a meta-analysis 
of the effects of cognitive remediation on cognitive functioning, symptoms and 
psychosocial functioning and reported effect sizes in the medium range for overall 
cognitive functioning (0.41).  Additionally, Grynszpan et al. (2010) reported that 






sizes in mind, a sample size of twenty-four participants was determined for the 
current study through the use of the following input parameters detailed in Table 3.1. 
 
Table 3.1: G* Power 3 Output from A Priori Sample Size Calculation  
ANOVA: Repeated measures within factors 
Input Effect size f 0.25 
 Alpha error prob 0.05 
Power 0.8 
Number of groups 1 
Number of measurements 4 
Corr among rep measures 0.5 
Nonsphericity correction 1 
Output Noncentrality parameter 12 
 Critical F 2.7375 
Numerator df 3 
Denominator df 69 
Total sample size 24 
Actual power 0.8168 
 
Previous studies using the same cognitive remediation software package had reported 
attrition rates varying between 9 per cent (McGurk et al., 2005) and 14 per cent 
(Cavallaro et al., 2009).  The project aimed to recruit a minimum of thirty-two 
participants to allow for a 25 per cent dropout rate to ensure the required numbers of 
participants completed the study to warrant adequate power for analyses.   
 
3.3  Participants 
Adult participants aged between 25 and 60 (mean age of 49.9) with a psychiatric 
diagnosis of schizophrenia or schizoaffective disorder as classified by the ICD10, 
were recruited for the study through the Psychiatric Rehabilitation and Adult Mental 








3.3.1  Inclusion  
o Participants had to be adults (aged 18 to 64) with a diagnosis of schizophrenia 
or schizoaffective disorder as classified by the ICD10. 
o Participants had to be in current contact with services in NHS Grampian 
o Participants had to be willing and able to commit to the full intervention 
o Participants had to be literate in English language and able to follow on 
screen instructions. 
 
3.3.2  Exclusion 
o Participants were excluded if they were acutely unwell. 
o Participants were excluded if they were involved in other research projects 
within NHS Grampian. 
 
3.4  Procedure  
Initially, an email was sent to consultant psychiatrists working in Psychiatric 
Rehabilitation and Adult Mental Health services within NHS Grampian, requesting 
permission to attend MDT meetings, to discuss the project and to identify potential 
participants.  The researcher (J.M) then attended MDT meetings to meet with 
healthcare professionals, give an overview of the study, answer questions and 
ascertain whether there were any potential participants under the care of each team.   
 
Healthcare professionals then gave patients who met the inclusion criteria, and had 
capacity to consent, an invitation letter (appendix 4) and an information sheet 






packs to suitable patients, with capacity to consent, rather than giving them out 
during routine appointments.  Interested patients were asked to contact the researcher 
directly, alternatively they gave their permission for their contact details to be passed 
onto the researcher and the researcher contacted them directly, following a waiting 
period of at least 24 hours.    
 
Any individuals who were interested in participating were invited to meet with the 
researcher for an initial appointment.  During this meeting, the information sheet was 
discussed and potential participants were given the opportunity to briefly engage 
with the CACR intervention in order to gain additional insight into the requirements 
of the study.  All participants were informed that they would be required to meet the 
researcher twice a week, for a five week period, to participate in the intervention.  
Additionally, they were informed that they would complete four assessments over 
the course of the research using the standardised outcome measures.  When 
individuals indicated they were interested in taking part in the research project, the 
consent form (appendix 6) was discussed and informed consent was obtained.  
Participants were given the opportunity to ask questions and were informed that their 
participation was voluntary and they could withdraw from the study at any time.  
After informed consent was obtained, a letter (appendix 7) was sent to participants’ 
GPs informing them of the research project and their patients’ participation. 
 
An appointment was scheduled for the baseline assessment, during which 
participants completed a cognitive assessment using the National Institute for Mental 






Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB), an assessment of 
functional capacity using the University of California in San Diego (UCSD) 
performance based skills assessment-brief (UPSA-brief) and an assessment of social 
functioning using three subtests of the Social Functioning Scale (SFS).  
Demographic information was also collected directly from participants at this stage.   
 
Following a four week control waiting period, the pre-intervention assessment was 
then completed and the participants started the CACR intervention (Cogpack 
professional version 8.34). The intervention was run by the researcher or a support 
worker, either individually or in groups of up to three participants.  During the 
intervention, participants met with the researcher or support worker for up to 50 
minutes, twice a week, for a five week period.  All participants were offered a total 
of ten sessions of CACR and were encouraged to complete at least five hours of the 
intervention.  Some patients had difficulty concentrating for 50 minutes and in such 
cases shorter sessions were offered to accommodate individual needs.  If participants 
completed less than five hours of CACR after attending ten appointments, they were 
offered additional appointments until the minimum of five hours had been 
completed. Where possible, participants were offered the opportunity of further 
appointments, to account for any missed appointments during the research project.  
During their attendance, participants engaged with the CACR intervention and 
completed tasks designed to train the cognitive deficits frequently found in 
individuals with a diagnosis of schizophrenia.  All participants were informed they 







After the intervention period, participants completed the post-intervention 
assessment and were then invited back for a follow-up assessment, one-month after 
completing the intervention.  During the one-month follow-up all participants were 
offered the opportunity to receive individual feedback on their performance during 
their assessment.   
 
3.5  Recruitment 
Initially  34 individuals expressed an interest in taking part, however, only 29 
individuals (85 per cent) went on to give informed consent to participate in the study.  
Three participants dropped out after completing the first assessment (two 
experienced a deterioration in mental health and one could not commit enough time 
to complete the project).  A further three participants dropped out after completing 
the second assessment (one experienced a deterioration in mental health and two 
could not commit enough time to complete the project).  Two participants dropped 
out after completing the post-intervention assessment.  In summary, a total of 
twenty-nine participants completed the initial assessment.  Of these, twenty-six 
completed the pre-intervention assessment and twenty-three completed both the 
CACR intervention and the post-intervention assessment.  At the time of analysis, 
eighteen participants had completed the one-month follow-up assessment.   
 
Throughout the study, contact was maintained with the consultant psychiatrists 
responsible for the participants’ care, to monitor the participants’ ongoing mental 
state and eligibility to take part in the study.  The recruitment process and number of 































3.6  Ethical considerations  
3.6.1  Ethical approval 
The methodology of the current study was reviewed by the University of Edinburgh.  
In addition, a formal application for ethical approval was submitted to the North of 
Scotland Research ethics Service (NRES) using the Integrated Research Application 
System for ethical applications.  Ethical approval for the project was granted and 
4 individuals did not 
attend initial 
appointment and 1 












2 males dropped out 
and 3 males unable 
to continue due to 
time constraints 
18 individuals 
completed            
1-month follow up 




29 individuals gave 












confirmed in writing on the 2
nd
 September 2011 (appendix 8).  Approval from the 
local Research and Development department was also granted and confirmed by 
letter on the 26
th
 September 2011 (appendix 9). 
 
3.6.2  Informed consent and confidentiality 
Informed consent was obtained from all participants prior to their participation in the 
research.  The clinical team/referrer of each potential participant assessed capacity to 
consent, prior to giving potential participants information about the research project.  
During the initial appointment with the researcher, the nature of the study was 
explained to all potential participants.  After reading the invitation letter (appendix 4) 
and participant information sheet (appendix 5), all participants provided signed 
informed consent (appendix 6) to confirm that they understood the nature of the 
study prior to their participation.  Each participant was given a copy of their signed 
consent form to keep and an additional copy was filed in their medical notes.   
 
Individuals were informed that participation was voluntary and they were free to 
withdraw from the study at any time.  It was also emphasised to participants that 
withdrawal from the study would not impact their ongoing care from NHS 
Grampian.  Finally, participants were informed that all data collected during the 
study would remain confidential and would not be shared with any healthcare 







3.6.3  Risks to participants 
There were minimal risks to participants identified during the course of the current 
study.  It was acknowledged that the intervention was a substantial time commitment 
for participants; therefore, refreshments were made available during the study.  
Additionally, participants were informed that they could take breaks as required 
during the intervention period and were offered shorter appointments if the 50 
minute appointment was deemed to be too long.  The researcher, where possible, 
offered to reschedule any appointments missed or cancelled by participants. 
 
3.7  Measures 
3.7.1  Demographic and clinical information 
Demographic and clinical information was collected from participants during the 
initial appointment.  In some cases, with permission, additional information 
regarding their diagnosis was obtained from the participants’ psychiatrists.  
Information obtained during the current study included: 
o Diagnosis 
o Date of birth/age 
o Gender 
o Inpatient/outpatient status 






3.7.2  Cognitive Functioning 
MATRICS consensus cognitive battery (Nuechterlein & Green, 2006). 
Although a number of studies have examined cognitive enhancing interventions in 
individuals with schizophrenia, the lack of a consensus cognitive battery for 
measuring changes in cognitive functioning has been a major obstacle in the 
comparison and evaluation of such interventions.  The NIMH Measurement and 
Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative 
developed a consensus cognitive battery that can be used to measure changes in 
cognitive functioning and evaluate cognitive enhancing interventions (Nuechterlein 
& Green, 2006).  Initially, the MATRICS initiative evaluated previous research to 
identify a common set of cognitive impairments in individuals with a diagnosis of 
schizophrenia.  This process identified seven separate cognitive domains that were 
found to be frequently impaired: speed of processing, attention/vigilance, working 
memory, verbal learning and memory, visual learning and memory, reasoning and 
problem solving and social cognition (Nuechterlein, Barch, Gold, Goldberg, Green & 
Heaton, 2004).  
 
This initial process led to the structured development of the MATRICS consensus 
cognitive battery (MCCB), which involved the evaluation of over 90 assessments, 
across the seven cognitive domains.  The final test battery selection was based on 
specific criteria relating to test-retest reliability, utility as a repeated measure, 
relationship to functional status, sensitivity in response to pharmacological agents 
and practicality for clinical trials and tolerability for patients (Nuechterlein et al., 
2008).  All of the assessments included in the final battery have at least acceptable 






minimise practice affects (Nuechterlein et al., 2008). The standardised battery was 
co-normed on a sample of 300 community-based individuals stratified by age, which 
allows for the comparison of scores using a common metric, something that has 
proved difficult in previous research. 
 
The MCCB has been utilised by a number of drug trials, and is recommended for use 
in clinical trials of cognitive remediation as a valid and sensitive measure of 
cognitive impairment in schizophrenia that is related to functional outcome (August 
el al., 2011). 
 
For the current study, the structured consideration of psychometric properties in the 
development of the battery resulted in the MCCB being the most suitable measure.  
Previous cognitive remediation studies have utilised multiple tests, with individual 
norms.  A clear advantage of using the MCCB is that the measure was co-normed on 
one sample, making it easier to draw comparisons between studies that utilise the 
MCCB.  It is envisaged that future cognitive remediation and pharmacological 
intervention studies will employ this measure and therefore allow direct comparisons 
to be drawn between the effects of various interventions.  The MCCB was 
specifically developed to measure change in trials of cognition enhancing 
interventions and it is considered to be the gold standard for measuring cognition in 








3.7.3  Functional Capacity 
The University of California in San Diego (UCSD) Performance Based Skills 
Assessment- brief (Patterson et al., 2001). 
Attempts to assess functioning in patients with a severe mental illness have 
previously involved the use of self-report measures, proxy rated measures, clinician 
rated measures and direct observations of behaviour.  Patterson et al. (2001) 
discussed the merits of each technique and highlighted that self-report measures may 
be influenced by clinical symptoms, that reliable proxy raters are not available for 
many individuals with severe mental illness and that clinician ratings are often based 
on only a brief clinical appointment with the individual.  In light of these 
weaknesses, Patterson et al. (2001) argued that performance-based measures of 
functional capacity offer a reliable and valid measure of functioning, free from some 
of the difficulties associated with alternative measures of functioning.  Performance-
based measures of functional capacity to perform everyday living skills are becoming 
more widely used as outcome measures in research involving individuals with severe 
mental illness (Patterson et al, 2006; Granholm et al., 2005; Dickenson et al., 2010; 
Murthy et al., 2012).   
 
One advantage of employing measures of functional capacity, which assesses an 
individual’s capacity to perform everyday activities, is that such measures are free 
from environmental and social factors that may impact on everyday functioning, and 
therefore provide a direct assessment of an individual’s functioning.  The popularity 






body of literature supporting the use of such measures in research (Mausbach et al., 
2009). 
 
The University of California in San Diego (UCSD) Performance Based Skills 
Assessment (UPSA) was developed to assess basic living skills in community-based 
individuals with schizophrenia, across the following five domains: Financial Skills, 
Communication, Organisation/Planning, Transportation and Household 
Management.  Scores for each subtest are transformed into a 0 to 10 scale to allow 
for comparison and then multiplied by 2 to give a total score out of 100, with higher 
scores reflecting higher functional capacity (Patterson et al, 2001).  Patterson et al. 
(2001) reported excellent inter-rater reliability (0.91) although it should be noted that 
this figure was only based on a subsample of twenty individuals.  Patterson et al. 
(2001) also reported significant correlations between UPSA scores and cognitive 
impairment and severity of negative symptoms.  Although Patterson et al. (2001) 
recommended the UPSA as a useful tool for assessing functional capacity in adults 
with severe mental illness, the findings were based on a relatively small sample size 
(50 individuals with a diagnosis of schizophrenia and 20 healthy controls).   
 
Despite this criticism, a number of studies have since provided further evidence for 
the utility of this measure.  Mausbach et al (2007) found evidence to support the 
sensitivity of this measure to predict living status, suggesting a cut-off score of 75 or 
80 as a predictor of independent living status. In addition to this, it has been 
demonstrated that the UPSA correlates with cognitive functioning as measured using 






Schizophrenia (BACS), r=.65 (Keefe et al., 2006).  Additionally, the UPSA was 
rated favourably in terms of tolerability by participants undergoing assessment 
(Green et al., 2008), suggesting that the measure is well received.  
 
The UPSA-brief is a shorter version of the UPSA, which consists of two of the five 
original subscales: financial and communication skills. Each of the two subscales 
gives a maximum score of 50 points, which are combined to give a total score 
ranging from 0 to 100 points, with higher scores reflecting higher levels of functional 
capacity.  Mausbach et al. (2007) found that the UPSA-brief total score was 
significantly correlated (r =.93) with the five-subscale UPSA; in addition, the UPSA-
brief and the UPSA did not differ significantly in their usefulness for predicting 
residential status, although the recommended cut-off for the UPSA-brief is 60.   
 
The test-retest reliability of the UPSA was investigated by Leifker et al. (2010) who 
found that the UPSA-brief reliabilities ranged from r =.66 to r =.81 for periods of up 
to 36 months.  Leifker et al. (2010) reported practice effects for the UPSA-brief 
ranging from 0.01 to 0.16 for periods up of up to 36 months, with the greatest effect 
size found over a 6-month period.  The challenge of practice effects was considered 
in the present study due to the short time frame between each assessment; however, it 
was noted that assessment measures are not without weaknesses and the additional 
advantages of the UPSA-brief resulted in it being included in the present study.  
Leifker et al. (2010) identified that relatively large changes in raw scores (21.32, SD 






interval; this finding provided clear guidance for the interpretation of scores in the 
current study.   
 
The UPSA-brief was selected for use in the current study, as it was recommended by 
the MATRICS working group conference on multi-site trails of cognitive 
remediation as an adequate short form measure of functional capacity (Keefe et al., 
2010), and it can be completed and scored in less than 10 minutes.  Permission was 
obtained from the author to use the UPSA-brief in the current study.  Approved 
adaptations were carried out, in line with previous adaptations for a European 
version, to localise the measure for use with a Scottish population (for example using 
British pounds instead of American dollars in the finance subtest). 
 
3.7.4  Social functioning 
 The Social Functioning Scale (Birchwood et al., 1990). 
It has been argued that impairment of social functioning may reflect a primary 
impairment in schizophrenia (Bellack et al., 1990).  The assessment of social 
functioning is therefore an important factor in ongoing treatment research.  The 
Social Functioning Scale (SFS) was developed to assess seven domains of 
functioning that are considered necessary for community functioning (Birchwood et 
al., 1990).  Items are scored on a four point scale, with higher scores reflecting a 
higher level of functioning.  The raw scores of the seven domains are converted into 







In a study involving 334 outpatients with a diagnosis of schizophrenia, and 100 
control subjects, Birchwood et al. (1990) reported high internal reliability (alpha of 
0.80) and inter-rater reliability (0.94).  Although this provides clear support for the 
utility of this measure, the inter-rater reliability was derived from a small sub sample 
of only 30.   
 
Although the SFS has reasonable psychometric properties, it was designed for use 
with community-based patients; therefore, its suitability for use with inpatients may 
be questionable.  Despite this criticism, the SFS has become a well utilised measure 
for research purposes to assess social functioning in individuals with severe mental 
illness.  A recent project funded by the National Institute of Mental Health, which 
aimed to enhance the measurement of real world outcomes through the evaluation of 
functioning measures, asked forty-eight experts to nominate scales that they believed 
best measured real world functioning.  This process resulted in 59 measures being 
identified, which were then reviewed by a panel and rated on a 9-point scale (1=poor, 
9=superb).  The SFS was rated as one of the superior measures and was selected for 
the next stage of the research, which involves a validation study that is currently 
ongoing (Leifker et al., 2011).  
 
Previous research has demonstrated that scores on the SFS are significantly 
correlated with neuropsychological test performance (Dickerson et al., 1996).  Such 
findings indicate that cognitive enhancing treatments may lead to improvements in 







The SFS was selected for use in the current study as it was free for use in research, it 
demonstrated good psychometric properties, the reference period for the scale was 
unspecified and each domain was given a scaled score, meaning that a shorter 
version of the SFS could be administered in the current study.  The SFS was obtained 
from the primary author, along with permission for use in the current research.  The 
current study made use of three subtests: withdrawal/social engagement, 
independence performance and independence competence.  The subscales that 
assessed functional capacity and functional performance were selected in order to 
keep in line with the distinction between functional capacity and functional 
performance.   
 
3.8  Intervention 
Cogpack professional software (version 8.34) is a computerised cognitive 
remediation package that was developed in Germany in 1985 and has been tested 
clinically throughout Europe in psychiatric populations since 1986.   The current 
version used in the study consisted of 64 programmes that can be used to train 
various cognitive skills including: visuomotor, comprehension, reaction, vigilance, 
memory, language, intellectual and professional skills (Marker, 2011).  Cogpack 
gives detailed instructions on-screen prior to starting tasks, and gives the opportunity 
of practice trials before starting the training series.   
 
3.8.1  Selection of Cogpack for current study 
There is growing literature supporting the use of Cogpack with patients with a 






can significantly improve cognitive functioning (McGurk et al., 2005; Cavallero et 
al., 2009; Sartory et al., 2005; Vaugh et al., 2005; Wolwer et al., 2005; Lindenmayor 
et al., 2008) and daily functioning (McGurk et al., 2005; Cavallero et al., 2009, 
Poletti et al., 2010) in this population. 
 
Additionally, Bender et al. (2004) investigated the subjective experience of using 
Cogpack in 64 patients with schizophrenia, and reported that the CACR training was 
rated as highly acceptable by participants and experienced as very effective.  In 
addition to this, following the training, self reported computer anxiety scores 
decreased, while subjective well-being scores significantly increased (Bender et al., 
2004).  The above findings highlight that Cogpack is well received by individuals 
and there was a reasonable evidence base supporting the decision to select Cogpack 
for use in the current study.   
 
3.8.2  Training series in current study 
A previous meta-analysis was used as guidance when deciding the lengths and 
number of sessions offered in the current study.  McGurk et al. (2007) demonstrated 
that the number of hours of cognitive remediation was not associated with the degree 
of improvement in cognitive functioning and therefore between five and fifteen hours 
of cognitive remediation were sufficient to produce changes in cognitive functioning.  
A further meta-analysis investigating the effects of CACR also reported that 
treatment duration and weekly frequency did not correlate significantly with effect 






offer a brief, intensive intervention of a minimum of 5 hoursof CACR in the form of 
two 50-minute appointments each week over a five week period.   
 
It was recognised that there would be some variability in participants’ capabilities 
and the amount of intervention completed.  For these purposes, it was decided that 
participants would complete a minimum of five hours of CACR across the ten 
sessions, and if they had not reached this standard following ten sessions of CACR, 
additional appointments would be offered until the amount of intervention was above 
five hours as recommended by previous research (McGurk et al., 2007). 
 
The current study employed ten Cogpack tasks to comprise a training series that 
trained attention/vigilance, speed of processing, working memory and visual 
memory.  For each session the ten tasks were presented in the same order and 
participants were encouraged to complete all of the tasks.  All tasks were presented 
in the permanently adaptive mode where possible.  Otherwise tasks were set at the 
easiest level initially and increased in difficulty after participants achieved 
approximately 80 per cent accuracy.  On completion of each of the ten tasks, 
participants were presented with comparative scores, which allowed them to track 
their progress over the course of the intervention period.  Individual differences in 
computer skills and ability resulted in some variation in the number of tasks 







Table 3.2: Description of Cogpack tasks used in training series 
Name of task Cognitive function Description of task 
On the road Attention/vigilance/visual 
learning 
You are driving along a road and have to pay 
attention to road signs and oncoming traffic.  
Sequence Attention/vigilance Observe numbers on screen and press a key if the 
particular rule was met.  
Comparisons Attention/speed of 
processing 
Pairs of strings must be compared.  Observe as 
quickly as possible whether the two match. 
Search Selective attention Find the number between 1 and 9 hidden in a picture 
full of symbols as quickly as possible. 
Ball Speed of processing Move the mouse to bounce the falling balls as many 
times as possible. 
UFO’s Speed of processing Catch UFOs with the mouse as fast as possible. 
Falling stars Attention/speed of 
processing 
Catch as many falling stars as possible. 
Reaction Speed of processing Press a button when a critical symbol is displayed on 
the screen. 
Route Working memory Make a mental note of the route a black circle takes 
along a street and retrace it. 
Money Working memory Decide whether the coins on the screen are enough 
money to pay the price given. 
 
3.9  Statistical analyses  
The MCCB was scored using a computer software programme provided by the 
distributor, and the T scores were exported into a database using Statistical Package 
for the Social Sciences (SPSS) software version 19.   The UPSA-brief and SFS 
subtests were scored by the researcher and the raw scores were entered into a 
Microsoft Excel worksheet developed by the researcher, which computed the 
adjusted scores appropriately.  These scores were then exported into a SPSS database 
for analyses.  All data were analysed using SPSS software version 19.  Descriptive 
analyses were conducted to interpret the demographic information and participant 
characteristics as follows: 
o Number of male and female participants 






o Clinical diagnosis 
o Current medication 
o Inpatient/outpatient status 
o Mean number of sessions completed 
 
A combination of parametric and non-parametric statistics was used to investigate 
the effects of CACR on cognitive functioning, functional capacity and everyday 
social functioning.  The data from the MCCB and the UPSA-brief met the 
assumptions required to use parametric tests and therefore repeated measures 
ANOVAs were used to investigate the effects of CACR on cognitive functioning and 
functional capacity.  The data from the SFS did not meet the assumptions required to 
use parametric tests, therefore, Friedman tests were used to investigate the effects of 
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4.1  Abstract 
 
Background: A recent review found computer-assisted cognitive remediation 
(CACR) improves cognition in individuals with schizophrenia with a medium effect 
(Grynszpan et al., 2011)..  There is limited research investigating whether the effects 
of brief CACR interventions are maintained over time and generalise to psychosocial 
functioning. 
 
Objective: The current study investigated the effects and durability of a brief CACR 
intervention on cognitive functioning, functional capacity and social functioning.     
 
Method: A repeated measures within-subjects design was conducted to investigate 
the effects of a five week CACR intervention.  Twenty-three individuals with a 
diagnosis of schizophrenia or schizoaffective disorder participated in the CACR 
intervention and completed outcome measures assessing cognition, functional 
capacity and social functioning.   
 
Results: Improvements were observed during the research project in the domains of 
speed of processing and reasoning/problem solving, as well as the total composite 
score.  When comparing the pre and post-intervention scores no significant effects 
were observed in cognition, functional capacity or social functioning.    
 
Conclusions: The improvements in speed of processing, reasoning and problem 
solving and the total composite score could not be solely attributed to the CACR 
intervention.  The findings were in line with previous research which found the 
effects of a pure CACR intervention do not generalise and lead to improvements in 
psychosocial functioning.   
 






4.2  Introduction 
 
4.2.1  Cognitive deficits in schizophrenia 
Schizophrenia is a severe mental illness characterised by profound disruptions in 
thinking, language, experience of emotions and perception (WHO, 2012).  There is 
now substantial evidence supporting the view that cognitive impairment is a 
pervasive and disabling core feature of schizophrenia (Gold, 2004; Elvevag & 
Goldberg, 2000).  Additionally, research has identified that cognitive deficits in 
individuals with schizophrenia can impair daily functioning to a greater degree than 
either positive or negative symptoms (Green, 1996).   
 
Nuechterlein et al. (2004) identified that impairments in speed of processing, 
attention/vigilance, working memory, verbal learning and memory, visual learning 
and memory, problem solving and social cognition were frequently found in 
individuals with schizophrenia.   During the onset of symptoms of schizophrenia, 
there appears to be a period of decline in cognitive functioning, followed by a period 
of stabilisation (Medalia et al., 2009).  Bilder et al. (2000) found a large generalised 
deficit in neuropsychological functioning of 1.5SD in patients with first-episode 
schizophrenia, compared to a healthy control group.  Additionally, Heaton et al. 
(2001) reported that level of cognitive impairment in individuals with schizophrenia 
remained stable despite changes in clinical state, both over a short-term period (mean 







Green et al. (2000) identified associations between specific cognitive domains and 
functional outcome measures in individuals with schizophrenia.  More specifically, 
secondary memory was linked with all outcome measures, immediate memory was 
linked with skill acquisition, executive functions was linked with community 
functioning and vigilance was linked to skill performance (Green et al., 2000).  This 
highlighted that cognitive functions are related to functional outcome in individuals 
with a diagnosis of schizophrenia; therefore, treatments aimed at improving cognitive 
functions may, in turn, improve psychosocial functioning and reduce level of 
disability in this population.   
 
Further studies have linked cognitive impairments to work performance (Bell et al., 
2001), everyday functioning capacity (Twamley et al., 2002) and quality of life 
(Mohamed et al., 2008).   A growing body of literature now demonstrates the direct 
link between cognitive functioning and psychosocial functioning, as a result there 
has been an increase in interest in treatments that improve cognitive functioning and 
whether these effects generalise to psychosocial functioning. 
 
4.2.2  What is cognitive remediation 
Wykes and Spaulding (2011) reported that a cognitive remediation experts’ 
workshop defined cognitive remediation therapy for schizophrenia as “a behavioural-
training based intervention that aims to improve cognitive processes (attention, 
memory, executive function, social cognition or metacognition) with the goal of 
durability and generalisation” (p84).   McGurk et al. (2007) conducted a meta-






a medium effect (0.41) for overall cognition, a small to medium effect (0.35) for 
functioning and a small effect (0.28) for symptoms.  Computer-assisted cognitive 
remediation (CACR) may have several advantages over more traditional methods 
that use paper and pencil tasks; hence there has been a growing interest in CACR 
recent years.   
 
4.2.3  Effects of CACR on cognitive functioning 
To date, only one review of 16 randomised controlled trials has evaluated the effects 
of CACR on cognition in individuals with a diagnosis of schizophrenia.  Grynszpan 
et al. (2011) found results in line with previous reviews of cognitive remediation, 
reporting that CACR had an effect size of 0.38 on general cognition.  Although 
Grynszpan et al. (2011) provided substantial evidence supporting the efficacy of 
CACR, a number of negative reports have also been published (Murthy et al., 2012; 
Dickinson et al., 2010).  These negative results may have reflected the fact that the 
intervention only targeted one cognitive domain (Murthy et al., 2012), or that the 
intervention programme used did not have an established evidence base (Dickinson 
et al., 2010).   These reports of negative results highlight the need for further 
investigations into the components of successful CACR to inform future treatments. 
   
4.2.4  Effects of CACR on psychosocial functioning 
Although there is evidence suggesting that cognitive remediation is effective at 
improving psychosocial functioning (McGurk et al., 2007), it remains unclear 
whether the effects of CACR generalise to psychosocial functioning.   There is 






different aspects of psychosocial functioning (Vita et al., 2010) and quality of life 
(Cavallaro et al., 2009; Poletti et al., 2010).   In addition to these encouraging results, 
a growing number of articles have found that CACR can significantly improve 
performance on vocational outcome measures, such as employment status, hours 
worked and money earned (Bell et al., 2005; Bell et al., 2008; Vauth et al., 2005; 
Lindenmayer et al., 2008; McGurk et al., 2009).   
 
Despite a growing number of papers reporting that CACR has a positive effect on 
various measures of psychosocial functioning, a number of papers have also 
provided negative results.  d’Amato et al. (2011) reported that CACR had significant 
effects on a number of cognitive functions, but these effects did not generalise to 
social autonomy or quality of life.  An additional study conducted by Hermanutz & 
Gestrich (1991), found no significant effect of CACR on clinicians’ ratings of social, 
occupational and psychological functioning as assessed by the Global Assessment 
Scale (GAS).   
 
A recent report from the Working Group Conference on Multisite Trial Design for 
Cognitive Remediation in Schizophrenia (Keefe et al., 2011) highlighted that 
functional outcome is influenced by a number of factors; therefore, a measure of 
functional capacity, such as the UPSA-brief, should be included in studies 







4.2.5 Aims of the current study 
The current article sought to expand on previous research in a number of ways.  
Firstly, the study will employ the MATRICS consensus cognitive battery (MCCB) as 
an outcome measure for cognitive assessment.  The MCCB is a reliable measure that 
was developed specifically to evaluate cognitive enhancing interventions.  It is 
sensitive to change, and has alternate forms for some subtests to allow for repeat 
assessment.  Previous research has made use of a variety of measures with multiple 
norms and it has been recommended that future studies would benefit from using the 
MCCB (Keefe et al., 2011).   
 
In addition to this, the current study aimed to expand the previous literature on the 
effects of brief CACR interventions, by examining the lasting effects of CACR at a 
one-month follow-up and by investigating any effects on functional capacity and 
everyday social functioning. It was hypothesised that CACR would improve 
cognitive functioning, functional capacity and everyday social functioning.  
 
4.3  Method 
4.3.1  Design 
The study employed a repeated measures within-subjects design, with participants 
acting as their own controls.  In order to investigate the effects of a brief CACR 
intervention on cognitive functioning, functional capacity and social functioning, 
participants completed the outcome measures at four time points throughout the 
study.  All participants were followed up one month post-intervention to investigate 







4.3.2  Participants 
Adult participants with a clinical diagnosis of schizophrenia or schizoaffective were 
recruited for the study through the Adult Mental Health and Psychiatric 
Rehabilitation services within NHS Grampian.  The current study employed the 
following inclusion/exclusion criteria: 
 
Inclusion 
o Participants had to be adults (aged 18 to 64) with a diagnosis of schizophrenia 
or schizoaffective disorder as classified by the ICD10 
o Participants had to be in current contact with services in NHS Grampian 
o Participants had to be willing and able to commit to the full intervention 
o Participants had to be literate in English language and able to follow on 
screen instructions 




o Participants were excluded if they were acutely unwell 
o Participants were excluded if they were involved in other research projects 
  
4.4  Procedure  
All participants were recruited from NHS Psychiatric Rehabilitation and Adult 
Mental Health services based in Grampian.  All participants gave written informed 






from participants and, with consent from participants, the psychiatrists involved in 
their care.  After completing the baseline assessment, participants entered a four 
week waiting period, after which they completed the pre-intervention assessment.  
Participants then engaged in the CACR intervention for approximately 50 minutes, 
twice a week where possible, for five weeks, with the aim of completing ten sessions 
in total.  After the intervention period, participants completed the post-intervention 
assessment and were then invited back for a follow-up assessment one month after 
completing the intervention.  At the follow-up appointment all participants were 
offered the opportunity to receive individual feedback on their performance during 
their assessments.   
 
4.4.1  Recruitment 
Initially thirty-four individuals expressed an interest in taking part; however, only 
twenty-nine individuals (85 per cent) went on to give informed consent to participate 
in the study.  Three participants dropped out after completing the first assessment 
(two experienced a deterioration in mental health and one could not commit enough 
time to complete the intervention).  A further three participants dropped out after 
completing the second assessment (one experienced a deterioration in mental health 
and two could not commit enough time to complete the intervention).  A further two 
participants dropped out after completing the post-intervention assessment and an 
additional three participants were not followed up due to time constraints on the 







In summary, a total of twenty-nine participants completed the initial assessment.  Of 
these, twenty-six completed the pre-intervention assessment, and twenty-three 
completed both the intervention and the post-intervention assessment.  At the time of 
analysis, one-month follow-up data was available for eighteen participants.  
Throughout the study, contact was maintained with the consultant psychiatrists 
responsible for participants’ care, to monitor their ongoing mental state and 
eligibility to participate in the study.  The recruitment process and number of 
participants completing each assessment can be seen in Figure 4.1. 
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2 males dropped out 
and 3 males unable 
to continue due to 
time constraints 
18 individuals 
completed            
1-month follow up 
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4.4.2  Ethical Approval 
The methodology of the current study was reviewed by the University of Edinburgh.  
In addition, ethical approval for the project was also obtained from the North of 
Scotland Research ethics Service (NRES) and local approval was also obtained from 
the NHS Grampian Research and Development department.  
 
4.5  Assessment 
Demographic information was collected once participants had given informed 
written consent.  Participants were assessed using the three outcome measures: 
Measurement and Treatment Research to Improve Cognition in Schizophrenia 
(MATRICS) Consensus Cognitive Battery (MCCB), University of California in San 
Diego (UCSD) Performance Based Skills Assessment-Brief (UPSA-brief) and three 
subtests from the Social Functioning Scale (SFS).  The outcome measures were 
completed at baseline, pre-intervention, post-intervention and at one-month follow-
up.  The assessments were completed by a trainee clinical psychologist, who also ran 
the CACR intervention sessions. 
 
4.5.1  Cognitive Functioning 
The MCCB was specifically developed to measure change in trials of cognition 
enhancing interventions.  It is considered to be an acceptable standard for measuring 
cognition in clinical trials of participants with a diagnosis of schizophrenia (Keefe et 
al., 2011).  The MCCB assesses cognitive functioning across seven domains, through 
ten subtests.  Raw scores are converted to adjusted T-scores for the seven cognitive 






of the MCCB were considered good, with the majority of tests obtaining an r value 
above 0.70 (Nuechterlein et al., 2008).  In addition to this, alternative forms are 
available for a number of the subtests, to minimise practice effects during multiple 
assessments over time.  The MCCB has been demonstrated as a valid and sensitive 
measure of cognitive impairment in schizophrenia, which is related to functional 
outcome (August et al., 2011).  
 
4.5.2  Functional capacity 
The UPSA-brief was designed to assess financial and communication skills in 
community based individuals with schizophrenia.  Each of the two subscales gives a 
maximum score of 50 points, which are combined to give a total score ranging from 
0 to 100 points; higher scores reflect higher levels of functional capacity.  The test-
retest reliability of the UPSA-brief was investigated by Leifker et al. (2010), who 
found that the reliability of the UPSA-brief ranged from r=.66 to r=.81 for periods of 
up to 36 months. In addition to this, it has been demonstrated that the UPSA 
correlates with cognitive functioning as measured using the MCCB, r=.61 (Green et 
al., 2008).   
 
4.5.3  Social functioning 
The Social Functioning Scale (SFS) was developed to assess seven domains of 
functioning that are considered crucial for community functioning (Birchwood et al., 
1990).  Items are scored on a four point scale, with higher scores reflecting a higher 
level of functioning.  The raw scores of the seven domains are converted into a 






three subtests were administered: social engagement/withdrawal, independence-
performance and independence-competence.  Birchwood et al.  (1990) reported high 
internal reliability (alpha of 0.80) and inter-rater reliability (0.94).  Additionally, the 
SFS was recently identified as a superior assessment of social functioning, according 
to a project funded by the National Institute of Mental Health, which aimed to 
enhance the measurement of real world outcomes through the evaluation of 
functioning measures (Leifker et al., 2011).  Previous research has demonstrated that 
scores on the SFS are significantly correlated with neuropsychological test 
performance (Dickerson et al., 1996).   
 
4.6  Intervention 
Cogpack professional software (version 8.34) is a computerised cognitive 
remediation package that was developed in Germany.  It has been clinically tested in 
psychiatric populations throughout Europe, since 1986.  The current version used in 
the study consisted of 64 programmes that can be used to train various cognitive 
skills including: visuomotor, comprehension, reaction, vigilance, memory, language, 
intellectual and professional skills (Marker, 2011).  A number of studies have 
reported that Cogpack interventions can significantly improve cognitive functioning 
(McGurk et al., 2005; Cavallero et al., 2009; Sartory et al., 2005; Vauth et al., 2005; 
Wolwer et al., 2005; Lindenmayor et al., 2008) and daily functioning (McGurk et al., 
2005; Cavallero et al., 2009, Poletti et al., 2010). 
 
In the current study, the intervention consisted of a standardised CACR training 






working memory and visual learning.  For each session, the tasks were presented in 
the same order and participants were encouraged to complete all of the tasks.  On 
completion of each task, participants were presented with comparative scores, which 
allowed them to track their progress over the course of the intervention period.  
Where possible, the Cogpack training series was presented in the permanently 
adaptive mode, to adjust to the performance of each participant and reduce any sense 
of failure.  The training took place either individually or in small groups of up to 
three participants with each participant working on their own computer.   
 
4.7  Statistical analyses  
Statistical Package for Social Sciences (SPSS) version 19 was used to analyse the 
data.  Exploratory analyses of the distribution of the data were conducted to 
investigate whether the data met the assumptions required to use parametric tests.  A 
combination of parametric and non-parametric tests was employed to investigate any 
changes in cognitive functioning, functional capacity and social functioning across 
the four time points. 
 
4.8  Results 
4.8.1  Group characteristics 
Of the thirty-four people who initially showed an interest in participating, twenty-
nine participants completed the baseline assessment, twenty-six completed the pre-
intervention assessment and twenty-three completed the CACR intervention and 
post-intervention assessment.  At the time of analysis, one-month follow-up data was 






participants who engaged in the CACR intervention can be seen in table 4.1.  
Participants completed between 250 and 480 minutes of CACR (M = 357; SD = 
63.5).  The total number of CACR sessions completed by participants ranged 
between 6 and 11 sessions (M = 8.6; SD = 1.44).   
 















The sample consisted of eighteen males (78 per cent) and five females (22 per cent).  
The age of the participants ranged from twenty-five to sixty-one (M = 49.9; SD = 
9.08).  Thirteen participants (57 per cent) had a clinical diagnosis of schizophrenia, 
seven (30 per cent) had a diagnosis of paranoid schizophrenia and three (13 per cent) 
had a diagnosis of schizoaffective disorder.  Six inpatients (26 per cent) and 
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seventeen community outpatients (74 per cent) participated in the current study.   Of 
the twenty-three participants, six (26 per cent) were being treated with typical 
antipsychotics.  The remaining seventeen participants (74 per cent) were being 
treated with atypical antipsychotics. 
 
4.8.2  Investigations of assumptions of normality  
Descriptive data and histograms (appendix 10) for each of the main variables were 
analysed in order to establish whether the data met the assumptions required to use 
parametric tests.  Field (2005) reported that in a small sample, a z score of skewness 
above 2.58 (or below -2.58) indicates that the degree of skewness is too large to meet 
the assumptions required to employ parametric tests.  Examination of z scores 
revealed that the data from two outcome measures: the MCCB and the UPSA-brief, 
appeared to meet the assumptions required to use parametric tests, therefore, repeated 
measures ANOVAs were used to investigate the effects of a five-week CACR 
intervention on cognitive functioning as assessed by the MCCB, and functional 
capacity as assessed by the UPSA-brief.  However, the data from the SFS did not 
meet the assumptions required to use parametric tests and therefore Friedman tests 
were used to investigate the effects of CACR on social functioning as assessed by the 
SFS. 
 
4.8.3  Bonferroni correction 
It is recognised that when conducting multiple comparisons there is an increased 
likelihood of finding a significant effect by chance alone (Field, 2005).  A Bonferroni 
correction controls for such errors, by dividing the significance level by the number 






comparisons, Bonferroni adjustments were employed in order to reduce the risk of 
Type I errors.  
 
4.8.4  Treatment effects on cognitive functioning 
Performance on the MCCB was assessed by calculating T scores for the seven 
cognitive domains and the total composite score.  Table 4.2 provides descriptive 
statistics for the scores obtained at the four assessments.  Repeated measures 
ANOVAs were conducted to investigate whether a five-week CACR intervention 
improved performance in any of the seven cognitive domains and the total composite 
score.  As multiple analyses were being conducted, effects were examined with a 
Bonferroni adjustment for the eight analyses, setting the alpha level at 0.00625 
(0.05/8).  Further post hoc investigations of main effects were conducted using 
pairwise comparisons with a Bonferroni adjustment.     
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Speed of processing 
The descriptive analyses highlighted that the highest mean T scores were obtained 
post-intervention and at the one-month follow up.  The results of the repeated 
measures ANOVA, examined with a Bonferroni adjustment, revealed that mean T 
scores on the speed of processing domain differed significantly between the four 




= .35).   
 
Post hoc pairwise comparisons with a Bonferroni adjustment (appendix 11)  revealed 
that, compared to baseline, participants perfomed significantly better on the speed of 
processing domain at post-intervention (p=.004) and at one-month follow-up 
(p=.002).  No other significant differences were found.  Although these results 
indicate a significant improvement in the speed of processing domain during the 
course of the research, pairwise comparisons revealed no significant difference 
between mean T scores obtained at the pre-intervention assessment and the post-
intervention assessment.  Therefore, these findings did not support the hypothesis 
that a CACR intervention would improve cognitive functioning.   
 
Attention/vigilance 
The descriptive analyses highlighted that the lowest mean T score was obtained on 
the baseline assessment, while the highest was obtained at the one-month follow up 
assessment.  The greatest increase in T scores occurred between the baseline 
assessment and the pre-intervention assessment.  The results of a repeated measures 
ANOVA, examined with a Bonferroni adjustment, revealed no significant difference 










=.07).   This finding did not support the hypothesis that a 
CACR intervention would improve cognitive functioning.   
 
Working memory 
The descriptive analyses highlighted that the lowest mean T score for the working 
memory domain was obtained at the baseline assessment, while the highest was 
obtained at the pre-intervention assessment.  The results of the repeated measures 
ANOVA, examined with a Bonferroni adjustment, revealed no significant difference 
in mean T scores on the working memory domain between the four assessments  (F 
(3, 48) = 2.328), p = .086, η
2
p =.13).   This finding did not support the hypothesis that 
a CACR intervention would improve cognitive functioning.   
 
Verbal learning 
The descriptive analyses highlighted that the lowest mean T score for the verbal 
learning domain was obtained at the baseline assessment, while the highest was 
obtained at the post-intervention assessment.   These scores suggest that there may 
have been some improvement in performance on the verbal learning domain 
following the intervention.  However, the results of the repeated measures ANOVA, 
examined with a Bonferroni adjustment, revealed no significant difference in mean T 
scores on the verbal learning domain between the the four assessments (F (3, 48) = 




=.03).   This finding did not support the hypothesis that a CACR 









The descriptive analyses highlighted that the lowest mean T score for the verbal 
learning domain was obtained at the baseline assessment, while the highest was 
obtained at the one-month follow up assessment.   These scores suggest that there 
may have been some improvement in performance on the visual learning domain 
following the intervention.  The results of the repeated measures ANOVA, examined 
with a Bonferroni adjustment, revealed no significant difference in mean T scores on 





=.17).  This finding did not support the hypothesis that a CACR intervention 
would improve cognitive functioning.   
 
Reasoning/problem solving 
The descriptive analyses highlighted that the lowest mean T score for the 
reasoning/problem solving domain was obtained at the baseline assessment, while 
the highest was obtained at the one-month follow up assessment.   These scores 
suggest that there may have been some improvement in performance following the 
intervention.  The results of the repeated measures ANOVA, examined with a 
Bonferroni adjustment, revealed a significant difference  in mean T scores on the on 
the reasoning/problem solving domain between the four assessments (F (3, 48) = 




= .37).   
 
Post hoc pairwise comparisons with a Bonferroni adjustment (appendix 11)   
revealed that, compared to baseline, participants perfomed significantly better on the 






follow-up (p=.001).  No other significant differences were foundAlthough these 
results indicate a significant improvement in the reasoning/problem solving domain 
during the course of the research, pairwise comparisons found  no significant 
difference between scores obtained on the pre-intervention assessment and the post-
intervention assessment scores.  Therefore, these findings did not support the 
hypothesis which stated  that a CACR intervention would improve cognitive 
functioning.   
 
Social cognition 
The descriptive analyses highlighted that the lowest mean T score for the social 
cognition domain was obtained at the one-month follow up assessment, while the 
highest was obtained at the post-intervention assessment.   The results of the repeated 
measures ANOVA, examined with a Bonferroni adjustment, revealed  no significant 
difference in mean T scores on the social cognition domain between the four 




= .06).  This finding did not support the 
hypothesis that a CACR intervention would improve cognitive functioning. 
 
Total composite score 
The descriptive analyses highlighted that the lowest mean T score for the overall 
composite score was obtained at the baseline assessment, while the highest was 
obtained at the one-month follow up assessment.   The results of the repeated 
measures ANOVA, examined with a Bonferroni adjustment, revealed  a significant 
difference in the mean composite scores obtained at the four assessments (F (3, 33) = 
8.178, p = .005, η
2






Post hoc pairwise comparisons with a Bonferroni adjustment (appendix 11) revealed 
that, compared to baseline, participants’ total composite scores were significantly 
higher at post-intervention (p = .018), and at one-month follow-up (p = .005).  
Additionally, participants’ total composite scores were significantly higher at the 
one-month follow-up assessment compared to the pre-intervention assessment 
(p=.046).  No significant difference was found between the total composite scores 
obtained at the pre-intervention and the post-intervention assessment.   
 
These results suggest that total composite scores for the MCCB did improve 
significantly during the couse of the research project, although there was not a 
significant improvement in scores obtained at the post-intervention compared to the 
pre-intervention assessments.  These findings may provide some support for the 
hypothesis that a CACR intervention would improve cognitive functioning.   
 
4.8.5  Treatment effects on functional capacity 
Performance on the UPSA-brief was assessed by converting the raw subtest scores to 
an adjusted score based on a 50-point scale.  The total score was then calculated by 
converting the raw score to an adjusted score based on a 100-point scale, with higher 
scores reflecting higher levels of functioning.  As can be seen from Table 4.3, the 
lowest total mean score was obtained at baseline, while the highest total mean score 































up n= 18  
 
Mean (SD) 






60.4  (19.61) 
32.0  (10.94) 







UPSA-b: The University of California in San Diego (UCSD) Performance Based Skills 
Assessment - brief 
a converted to a 100-point scale with higher scores reflecting higher levels of functioning 
b converted to a 50-point scale with higher scores reflecting higher levels of functioning 
 
Repeated measures ANOVAs were conducted to investigate whether a five-week 
CACR intervention improved performance in either of the two subtests and the total 
UPSA-brief score.  As multiple analyses were being conducted, effects were 
examined with a Bonferroni adjustment for the three analyses, setting the alpha level 
at 0.01666 (0.05/3).   
 
The results of the repeated measures ANOVAs, examined with Bonferroni 
adjustments, revealed no significant differences in mean scores between the four 
assessments, on the financial subtest (F (3, 51) = .132, p = .941, η
2 
= .008), the 
communication subtest (F (3, 51) = 2.400, p = .079, η
2 
= .12), or the UPSA-brief total 
score (F (3, 51 = 2.054, p = .118, η
2 
= .11).  These findings provided no evidence to 
support to the  hypothesis that a five-week CACR intervention would improve 
functional capacity as assessed by the UPSA-brief.   
 
4.8.6  Treatment effects on social functioning 
Performance on the SFS subtests was assessed by calculating the raw subtest scores 






higher scores reflecting higher levels of functioning.  Table 4.5 provides descriptive 
statistics for the scores obtained on the SFS at the four assessments.   
 




























97 (91, 100) 
107 (98, 112) 
107 (102, 110) 
 
97 (89, 105) 
107 (96, 114) 
107 (99, 110) 
 
100 (94, 105) 
107 (104, 114) 
107 (101, 110) 
 
98 (93, 105) 
104 (96, 115) 
109 (103, 111) 
SFS: Social Functioning Scale 
a. converted to a scaled score with a mean of 100 and SD 10. 
 
Friedman tests were conducted to investigate whether a five-week CACR 
intervention improved performance in any of the three subscales of the SFS.  As 
multiple analyses were conducted, effects were examined with a Bonferroni 
adjustment for the three analyses, setting the alpha level at 0.01666 (0.05/3).  The 
Friedman tests revealed no significant differences in scaled scores between 
assessments on the withdrawal subscale (X
2
 (3) = 6.258, p = .098), the 
independence-performance subscale (X
2
 (3) = 4.232, p= .240), or the independence-
competence subscale (X
2
 (3) = 2.379, p = .511).  These findings provided no 
evidence to support the hypothesis that a five-week CACR intervention would 
improve social functioning as assessed by the SFS.   
 
4.9  Discussion 
This study aimed to evaluate the effects of a brief CACR intervention on cognitive 






or schizoaffective disorder.  The study employed the gold standard tool for assessing 
cognitive functioning across time, and followed recommendations set out by experts 
in the field to include a measure of functional capacity (Keefe et al., 2011).  The 
participants received up to eight hours of training over a five week period and all 
participants except one completed more than five hours of training; the minimum 
number of hours shown to be effective in this population (McGurk et al. 2007). 
 
Three outcome measures were assessed during this study: neuropsychological tests 
that were not related to any of the training exercises (MCCB), a measure of 
functional capacity (UPSA-brief) and a measure of real world social functioning 
(SFS).   
 
The numbers needed for a control group were not attainable in the current research, 
therefore, participants acted as their own controls.  The descriptive analyses 
highlighted an increase in mean T scores between the baseline assessment and the 
pre-intervention assessment on all of the seven cognitive domains and the total 
composite score on the MCCB.  These increases may reflect practice effects 
associated with the MCCB.  However, further statistical analyses revealed no 
significant differences between any of the T scores obtained on the MCCB at the 
baseline assessment and the pre-intervention assessment.  Similarly, although there 
was an increase in the adjusted scores obtained on the UPSA-brief at the pre-








The time scale of the current research resulted in just four weeks between 
assessments.  Although the increases in T scores between the baseline assessment 
and the pre-intervention assessments were not statistically significant, this time scale 
would have benefited from being increased in order to reduce any associated practice 
effects of repeated assessments. 
 
4.9.1 Patient experience 
Generally, patients engaged well with the CACR intervention and reported feeling a 
sense of enjoyment from completing the computer tasks.  Only one patient requested 
to stop the intervention prior to completing the minimum recommended 300 minutes, 
due to difficulties travelling to the hospital.  Qualitative feedback from participants 
indicated that more variation in the tasks being completed would have been 
preferred.  It was noted that the current research project aimed to evaluate a 
standardised treatment that consistent of 10 separate tasks, but a more varied 
approach that is tailored to individual’s cognitive weaknesses could be implemented 
if the intervention was introduced into local services.  
 
4.9.2 Effects on cognition 
When comparing the pre-intervention and post-intervention T scores obtained on the 
seven cognitive domains and the total composite score, the current study found no 
evidence of any benefits of a brief CACR intervention on cognitive functioning.  
Previous research has reported that CACR has a medium effect (d = 0.38) on general 
cognition (Grynszpan, 2010), and that a minimum of five hours of cognitive 






(1997) found that six sessions of CACR did not improve attention in individuals with 
schizophrenia.  In the current study, participants completed an average of 5.95 hours, 
which is a similar dose to that offered by Field (1997).  Taken together, these 
findings suggest that six hours of CACR is not sufficient to improve cognitive 
functioning in this population.     
 
Hermanutz & Gestrich (1991) found that eight sessions was sufficient to improve 
cognition, while Medalia (2001) reported a significant effect on problem solving 
skills in individuals with schizophrenia following ten sessions of CACR.  It was 
acknowledged that the amount of intervention offered in the current study was 
relatively low in comparison to the amount offered in the existing published research.  
It may be that the dose of intervention in the current study was just below what is 
needed to improve cognitive functioning.   However, the findings of the current study 
supplement the existing literature reporting negative results for brief CACR 
interventions (Field, 1997) and longer-term CACR interventions (Murthy et al., 
2012; Dickinson et al., 2010). 
 
Despite the lack of improvement in scores from pre-intervention to post intervention, 
the current study did find significant improvements in two of the seven cognitive 
domains, as well as the total composite scores.  It is worth noting that scores on the 
speed of processing and the reasoning/problem solving domain, were significantly 
better at the one-month follow-up and the post-intervention assessment than the 
scores obtained at baseline.  These findings highlight that both speed of processing 






the CACR intervention may have provided some benefit on cognition.  Although 
encouraging, these improvements in scores can not be solely attributed to the CACR 
intervention, as no significant differences in performance were found between scores 
obtained at the pre-intervention and the post–intervention assessments. 
 
Interestingly, the mean total composite score, at both the one-month follow-up and 
the post-intervention assessment, was significantly higher than the mean score at 
baseline. Furthermore, the participants’ total composite score was significantly 
higher at the one-month follow-up compared to the pre-intervention assessment.  
These findings indicate that there was an improvement in overall cognition during 
the course of the research project.   
 
To calculate a total composite score, participants had to complete all 10 subtests of 
the MCCB.  Five participants refused to complete a subtest on the MCCB and 
therefore the total composite scores, at all four assessment points, were only 
available for thirteen participants.  Medalia & Richardson (2005) highlighted that 
intrinsic motivation was an important factor in predicting successful responses to 
CACR.  It is possible that the thirteen individuals who completed all MCCB subtests 
had higher motivation and, as a result, had a more positive treatment outcome on 
general cognition.  Future research into CACR involving measures of motivation 






4.9.3 Effects on psychosocial functioning 
The results of the current study found that CACR did not significantly improve 
functional capacity or social functioning in individuals with schizophrenia or 
schizoaffective disorder.  With regards to the UPSA-brief, Leifker et al. (2010) 
identified that relatively large changes in raw scores (21.32, SD 1.06) would be 
required between assessments to exceed a 90 per cent confidence interval and reflect 
a true change in functional capacity.  Although there was some improvement in mean 
scores obtained on the UPSA-brief across assessments, these changes were not 
statistically significant, and did not exceed the improvement suggested by Leifker et 
al. (2010).  Similarly, there were no observed improvements on any of the three 
subscales of the SFS.   
 
Only a small number of studies have investigated the effects of brief CACR 
interventions, and only one study (Hermanutz & Gestrich, 1991) was found that 
investigated whether any effects of CACR generalise to functional outcome. The 
results of the current study are in line with previous findings and suggest that a brief 
CACR intervention cannot significantly improve psychosocial functioning on its 
own.  Additionally, the findings here also reflect those reported by Murthy et al. 
(2012) and Dickinson et al. (2010), as CACR did not improve functional capacity in 
individuals with schizophrenia or schizoaffective disorder.   
 
Bowie et al., (2012) investigated whether the effects of a CACR intervention 
generalised to functional capacity and real world functioning when offered as a pure 






highlighted that improvement in functional capacity was greater following a 
combined treatment, however, improvement in real world functioning was not 
observed following a pure CACR intervention (Bowie et al., 2012).  Previous 
literature suggests that the positive effects of CACR generalise to psychosocial 
functioning when it is offered as part of a wider intervention, such as vocational 
rehabilitation (Bell et al., 2005; Bell et al., 2008; Vauth et al., 2005; McGurk et al., 
2009) or functional skills training (Bowie, 2012).   
 
The current study offered a pure CACR intervention, hence it adds to previous 
literature reporting that pure CACR interventions do not improve functional capacity 
or everyday functioning (Hermanutz & Gestrich, 1991; Murthy et al., 2012; 
Dickinson et al., 2010; Bowie et al., 2012).  Offering CACR as part of a wider 
intervention was beyond the scope of the current project, but it was recognised that 
future research would benefit from comparing the effects of offering CACR as part 
of a wider intervention. 
 
4.9.4 Patient characteristics 
Many of the participants in the current study were recruited through the severe and 
enduring service and had experienced chronic mental health difficulties for 
prolonged periods of time.  Medalia & Richardson (2005) found that individuals 
rated as less impaired on the PANSS made greater improvements after CACR 
interventions.  The lack of findings in the current study may reflect a greater degree 
of impairment in the individuals that participated, in comparison to participants in 






of impairment do not benefit from brief interventions, but require CACR with a 
longer duration to gain any benefits. 
 
There is also some evidence indicating that cognitive remediation may be more 
beneficial when offered to individuals during the prodromal stage of schizophrenia as 
an early intervention (Rauchensteiner et al., 2011).  Future research would benefit 
from investigating participant characteristics further, in order to establish whether 
there is an optimum time for offering CACR and whether some individuals are more 
likely to benefit than others (Wykes & Spaulding, 2011).    
 
Due to the anticipated difficulties in recruitment, and the relatively short time frame 
for completion of the project, the current study did not employ stringent inclusion 
and exclusion criteria, therefore, confounding variables may have impacted on 
participants’ scores on the outcome measures.  Comparative research has tended to 
recruit participants who are deemed to be stable on medication for a specified time 
period, although the criterion for defining this varies considerably between studies.  
It was acknowledged that changes in medication, mental state fluctuation or 
substance misuse could have impacted on participants’ cognitive functioning in the 
current study.  More stringent inclusion/exclusion criteria would have been beneficial 
to conduct a more rigorous investigation and draw firmer conclusions about the 







4.9.5 Intervention characteristics 
Previous research has identified that between five and fifteen hours of cognitive 
remediation was sufficient to improve cognition in individuals with schizophrenia or 
schizoaffective disorder.  However, the findings of the current study, along with 
previous research conducted by Field (1997), suggest that a brief CACR intervention 
on its own does not improve cognition in this population.   Keefe et al. (2011) 
defined a short-term trial of cognitive remediation as a twelve-week intervention.  
The results of the current study along with this definition, would suggest that brief 
interventions need to be longer that the five week period employed in this research, 
to significantly improve cognitive functioning.   
 
The current study aimed to investigate the effects of a brief five week CACR 
intervention, which consisted of two 50 minute sessions per week.  Medalia and 
Richardson (2005) found that individuals who completed a high intensity 
intervention (less than 128 days) benefited with a large effect (d = 1.46), compared to 
those who completed a lower intensity intervention (more than 128 days), who 
benefited with a smaller effect (d = .26).  Medalia and Richardson (2005) also 
reported that CACR was required to be offered twice a week in order to see gains.  
Although this was the intention of the current study, it was noted that the majority of 
participants missed at least one session and it proved difficult to maintain this 
intensity level throughout.  Therefore, future research may benefit from offering the 
intervention three times per week, to allow for potential missed appointments.  It was 
recognised that the intervention used in the current study may have been more 






The current study offered a relatively brief CACR intervention in comparison to 
much of the published research, and the views of Keefe et al. (2011) who defined a 
brief cognitive remediation intervention as lasting for 12-weeks.  Although it is of 
great clinical benefit to establish whether a brief intervention can improve cognition 
and psychosocial functioning in individuals with schizophrenia or schizoaffective 
disorder, the findings of the current study suggest that the intervention used was too 
short to foster any observable gains between in the scores obtained at pre-
intervention and post- intervention.  The current study also used a standard training 
series for all participants, to allow for the evaluation of a particular training series.  
Employing CACR within clinical settings would involve developing personalised 
training series’ to address each individual’s cognitive weaknesses.  The current study 
may have also benefited from tailoring the training series to each participant, rather 
than relying on a set training series. 
 
Finally, this study may have been slightly underpowered.  The original power 
calculation required twenty-four participants to complete the entire project, although 
twenty-three participants completed the intervention and post-intervention 
assessment, only eighteen participants completed the one-month follow up.   
 
4.9.6  Strengths and limitations of the study 
The current study adds to the evidence base by investigating the effects and 
durability of a brief CACR intervention on cognition and psychosocial functioning.  
A clear strength of the current study was that it employed outcome measures that are 






to ensure the training series did not make use of tasks similar to those used in the 
MCCB, in order to avoid any potential effects being the result of an underlying 
practice effect.  
 
The current study had a number of limitations.  It was not possible to employ any 
form of blinding techniques, as such, both the participants and the assessor were 
aware of the purpose of the study and the purpose of assessment at each time point.  
This is a clear weakness of the project, but formal blinding techniques were beyond 
the scope of the current project due to staffing limitations.  
 
The inclusion/exclusion criteria for the current study were kept relatively broad due 
to perceived difficulties of recruitment.  This resulted in two participants with current 
substance misuse difficulties being enrolled in the study.  Additionally, the 
researcher was aware that mental state fluctuated in some participants during the 
course of the research and that medication did not remain stable in all participants 
throughout the duration of the research.  Such confounding variables may have little 
impact on long-term trials but could affect the results of brief intervention studies.   
 
4.10  Conclusions 
The current study aimed to evaluate the effects of a brief CACR intervention on 
cognitive functioning as assessed by the MCCB, on functional capacity as assessed 
by the UPSA-brief and on social functioning as assessed by the SFS.  The results of 
the study found no significant effect of CACR on any of the three outcome measures 






improvements were observed over the course of the research on the domains of speed 
of processing, reasoning and problems solving, as well as the total composite score.  
The results suggest that a brief CACR intervention was not effective at improving 
cognitive functioning, functional capacity or social functioning in individuals with 
schizophrenia or schizoaffective disorder.  Further studies investigating the effects of 
CACR would benefit from examining participant characteristics and offering CACR 
as part of a wider psychosocial intervention.  Additionally, future studies may benefit 
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tracking and for a wealth of resources including FAQs and tips on article preparation, submission and 
more.  
11. The Later Stages  
The corresponding author will receive an email alert containing a link to a web site. A working e-mail 
address must therefore be provided for the corresponding author. The proof can be downloaded as 
a PDF (portable document format) file from this site. Acrobat Reader will be required in order to 
read this file. This software can be downloaded (free of charge) from the following web site: 
http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, 
read on screen and annotated direct in the PDF. Corrections can also be supplied by hard copy if 
preferred. Further instructions will be sent with the proof. Hard copy proofs will be posted if no e-
mail address is available. Excessive changes made by the author in the proofs, excluding typesetting 
errors, will be charged separately.  
12. Early View  
The British Journal of Psychology is covered by the Early View service on Wiley Online Library. Early 
View articles are complete full-text articles published online in advance of their publication in a 
printed issue. Articles are therefore available as soon as they are ready, rather than having to wait 
for the next scheduled print issue. Early View articles are complete and final. They have been fully 
reviewed, revised and edited for publication, and the authors’ final corrections have been 
incorporated. Because they are in final form, no changes can be made after online publication. The 
nature of Early View articles means that they do not yet have volume, issue or page numbers, so 
they cannot be cited in the traditional way. They are cited using their Digital Object Identifier (DOI) 
with no volume and issue or pagination information. E.g., Jones, A.B. (2010). Human rights Issues. 
Human Rights Journal. Advance online publication. doi:10.1111/j.1467-9299.2010.00300.x 
Further information about the process of peer review and production can be found in this document: 






Appendix 2. Quality criteria scoring guidelines 
 
1.1) The study addresses an appropriate and clearly focused question. 
Well-covered (2) A clear description of an appropriate focused question is provided. 
Adequately addressed (1) A description of a focused question is provided 
Poorly  addressed (0) It is not clear what the focused question is or there may be multiply 
questions. 
Not  addressed (0) There is no description of a focused question 
Not reported (0) A question mentioned but insufficient detail provided 




1.2) The assignment of subjects to treatment groups is randomised. 
Well-covered (2) Randomisation is clearly described and an appropriate method was 
used. 
Adequately addressed (1) Randomisation is carried out but no description of method given. 
Poorly  addressed (0) Randomisation is carried out through the use of inappropriate 
method (alternate allocation, allocation by date of birth, or day of 
the week attending a clinic). 
Not  addressed (0) Randomisation was not carried out or described. 
Not reported (0) Insufficient information given to assess randomization process. 




1.3) An adequate concealment method is used. 
Well-covered (2) Concealment is clearly described and an appropriate method was 
used to ensure researcher unaware of subject group allocation at 
the time they enter the study. 
Adequately addressed (1) Concealment is carried out to ensure researcher unaware of 
subject group allocation at the time they enter the study but no 
description of method given. 
Poorly  addressed (0) Concealment was partially carried out (e.g. some researchers 
unaware of subject group allocation at the time they entered the 
study).  
Not  addressed (0) No methods of concealment used. 
Not reported (0) Insufficient information given to assess concealment.  




1.4) Subjects and investigators are kept ‘blind’ about treatment allocation. 
Well-covered (2) Both the patient and researcher conducting the outcome 




The researcher conducting the outcome assessments are blind to 
conditions but description not given. 
Poorly  addressed (0) Blinding is carried out through the use of inappropriate method or 
was partially carried out. 
Not  addressed (0) No blinding procedures carried out or described. 
Not reported (0) Insufficient information given to assess blinding.  









1.5) The treatment and control groups are similar at the start of the trial. 
Well-covered (2) Clear details of baseline characteristics between groups. No 
difference between groups or differences controlled for.  
Adequately addressed 
(1) 
Reasonable detail of baseline characteristics between groups, and 
reasonably similar at baseline. 
Poorly  addressed (0) Baseline characteristics assessed but limited description provided or 
groups different at baseline and not controlled for. 
Not  addressed (0) Baseline characteristics not assessed or not reported. 
Not reported (0) Insufficient information given to assess whether treatment was only 
difference.  




1.6) The only difference between groups is the treatment under investigation. 
Well-covered (2) Detailed consideration has been to this point and it is clear that the 
treatment is the only difference between groups. 
Adequately addressed 
(1) 
Some consideration has been to this point and it is likely that the 
treatment is the only difference between groups. 
Poorly  addressed (0) Consideration has been given to this point but limited description 
given and it is unclear whether the treatment was the only difference 
between groups. 
Not  addressed (0) No consideration has been given to this point 
Not reported (0) Insufficient information given to assess whether treatment was only 
difference.  




1.7). All relevant outcomes are measured in a standard, valid and reliable way. 
Well-covered (2) Outcome measures clearly described and acceptable/good 
robustness for use with individuals with schizophrenia. 
Adequately addressed 
(1) 
Outcome measures acceptable/good robustness but not designed for 
use with individuals with schizophrenia. 
Poorly  addressed (0) Outcome measures poorly described and less robust. 
Not  addressed (0) Outcome measures used were not robust (not standardised in any 
way)  
Not reported (0) Insufficient information given to assess whether measures were 
robust. 




1.8) What percentage of the individuals or clusters recruited into each treatment arm of the 
study dropped out? 
Well-covered (2) A detailed description of the number of drop outs in each treatment 
arm was given and consideration to the reasons for this. 
Adequately addressed (1) A description of the number of drop outs in each treatment arm was 
given. 
Poorly  addressed (0) No description of drop outs given but numbers can be identified 
from tables etc. 
Not  addressed (0) No description of drop outs given. 
Not reported (0) Insufficient information given to assess what percentage of 
individuals in each treatment arm dropped out.  









1.9 All the subjects are analysed in the groups to which they were randomly allocated 
(often referred to as intention to treat analysis).  
 
Well-covered (2) Intention-to-treat analyses are well described and all subjects 
analysed in their appropriate group. 
Adequately addressed (1) Intention-to-treat analyses was mentioned but not described in any 
detail. 
Poorly  addressed (0) It was not clear if intention-to-treat analyses was used. 
Not  addressed (0) No intention-to-treat analysis was used 
Not reported (0) Insufficient information given to assess whether intention-to-treat 
analyses was used. 




1.10) Where the study is carried out at more than one site, results are comparable for all 
sites 
Well-covered (2) A detailed description of the results from each site is provided and 
consideration is given as to whether the results are comparable. 
Adequately addressed (1) Some description of the results from each site is provided and 
consideration is given as to whether the results are comparable. 
Poorly  addressed (0) description of the results from each site is provided and 
consideration is given as to whether the results are comparable 
Not  addressed (0) No description of the results from each site is provided and no 
consideration is given as to whether the results are comparable. 
Not reported (0) Insufficient information given to assess whether the results are 
comparable across sites.  







Appendix 3.  Studies excluded from the review. 
Authors Reason for exclusion 
Fiszdon et al.(2004) Data not available 
Fisher (2010) Duplicate data (Fisher 2009) 
Hogarty (2006) Duplicate data (Hogarty, 2004) 
Lindenmayor et al (2008) Mixed population 
McGurk et al (2009) Mixed population 
Kurtz et al.(2009) No control group 
Rauchensteiner et al. (2011) No control group 
Rudnick et al. (2009) No control group 
Surti et al. (2011) No control group   
Benedict et al .(1994) No post symptoms assessment 
Kurtz et al. (2008) No post symptoms assessment 
McGurk (2007) No post symptoms assessment 
Fiszdon (2006) Not CACR 
Luengo (2003) Not CACR 
Olbrich (1990) Not CACR 
Spaulding (1999) Not CACR 
Lecardeur (2009) Not CACR  
Lewis (2003) Not CACR  
Bark (2003) Not randomised 
Heydebrand et al. (2007) Review paper 
Medalia (2009) Review paper 
Roder (2006) Review paper 
Vesterager et al. (2011) Study protocol 
Bell et al.  (2005) Symptoms not assessed 
Bell et al. (2007) Symptoms not assessed 
Bell et al. (2008) Symptoms not assessed 
Bellack et al. (2005) Symptoms not assessed 
Burda et al. (1994) Symptoms not assessed 
Cassidy (1996) Symptoms not assessed 
Eack (2007) Symptoms not assessed 
Greig et al.(2007) Symptoms not assessed 
Kurtz et al. (2007) Symptoms not assessed 
Medalia (2000) Symptoms not assessed 
Medalia (2001) Symptoms not assessed 
Medalia (2002) Symptoms not assessed 
Sartory et al. (2005) Symptoms not assessed 
Cooper et al.(1999) Symptoms not assessed 
Field et al. (1997) Symptoms not assessed 

















                                                                                                                                               
Psychiatric Rehabilitation Department                         Date: 
First Floor      Enquiries to: Joanne 
MacLeod 
Old Admin Block     Telephone: 01224 557474 








Your clinician has given you this letter of invitation to inform you of a research project that you may 
be interested in taking part in. 
 
Mental health conditions can often affect a person’s memory and cognitive skills.  You are being 
invited to take part in a research project that is investigating a treatment that can improve memory and 
cognitive skills in individuals with mental health conditions. 
 
I have enclosed a participant information sheet which will explain the project in more detail.  If you 
are willing to participate in the project or would like further information please contact me on 01224 
557474.  Alternatively, you can ask your clinician to pass you name and contact number to me and I 
will contact you to discuss the project further. 
 
With many thanks for taking the time to read this letter 
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Appendix 5: Participant Information Sheet. 
                                                                                     
Participant Information Sheet 
 
Project Title: Cognitive remediation in schizophrenia 
 
You are being invited to participate in a research study. Before you decide whether to 
participate, it is important for you to understand why the research is being done and 
what it will involve. One of our team will go through the information sheet with 
you and answer any questions you have.  We would like to stress that you do not 
have to accept this invitation and should only agree to take part if you want to. 
 
Project Aims & Objectives 
If you have a mental health condition your memory and cognitive skills can often be 
affected.  The aim of this research study is to evaluate a treatment that aims to 
improve memory and cognitive skills in people with a mental health condition.  The 
study will also investigate whether the treatment can improve daily living skills. 
 
Why have I been chosen to take part? 
Individuals who have a diagnosis such as schizophrenia are being invited to take part 
in this study.   
 
Do I have to take part? 
Participation in the research project is voluntary, and you can withdraw from the 
study at any time.  Refusal to take part in the research project will not impact on your 
ongoing care from NHS Grampian.   
 
What will happen if I take part? 
If you decide to take part, you will be asked to attend the psychiatric rehabilitation 
department for 50 minutes, twice a week over a five week period.  During this time 
you will be asked to complete some tasks on a computer, but you do not need to have 
good computer skills to take part in the project.  You will also be asked to meet with 
the researcher on four occasions to complete a number of paper and pencil tasks that 
will be used to investigate whether the treatment has improved your cognitive skills.  
 
Are there any risks in taking part? 
There are no known physical or mental risks associated with this type of research.   
 
 
Are there any benefits in taking part? 
There are a number of benefits to taking part in the research project.  Participants 
will take part in a treatment program that has been shown to improve cognitive skills 
such as memory, concentration and problem solving. The findings of this study will 
also be used to inform and improve treatment for patients with mental health 









All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your interests.  This study has been reviewed 
and approved by the North of Scotland Research Ethics Committee.  
 
Will my participation be kept confidential? 
All information collected during the project is completely confidential and only the 
researcher has access to this information.  Your GP will be informed of your 
participation in the study. 
 
What will happen to the results of the study? 
This research is being carried out as part of a Doctorate in Clinical Psychology and 
will be written up as a thesis and submitted to the University of Edinburgh.  All 
participants will be offered the opportunity to have individual feedback of their 
personal results. The results of this research project may be published at a future date 
in an academic journal.  No one participating in the study will be identifiable in any 
resulting publications. 
 
What will happen if I want to stop taking part? 
You may withdraw from the research project at any time without having to give a 
reason.  If you decide to withdraw, you can request that any data collected will not be 
used as part of the research project. 
 
Who can I contact if I have further questions? 
If you have any questions or would like further information about the project contact: 
 
Joanne MacLeod, Trainee Clinical Psychologist 
Psychiatric Rehabilitation Department, First Floor, Old Admin Block, Royal Cornhill 
Hospital, Aberdeen. 
Telephone:  01224 557474 
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Appendix 6: Participant Consent Form. 
 
           
Participant Consent Form 
 
Study Title:  Cognitive remediation in schizophrenia 
 
Researcher: Joanne MacLeod, Trainee Clinical Psychologist 
 
In order to participate in this research project, it is necessary that you give your informed consent. By 
signing this informed consent form you are indicating that you understand the nature of the study and 
that you agree to participate in the research.  Please consider the following points before signing: 
   
1. I have read and understood the participant information sheet  
and have been given the opportunity to ask questions about  
the research project. 
 
2.  I understand that my identity will not be linked with my data,  
and that all information I provide will remain confidential. 
 
3. I agree to my GP being informed about my participation in the research 
project. 
 
4. I understand that participation in research is voluntary, and that, 
after any individual research project has began, I may 
withdraw from the project at any time. 
 
By signing this form I am stating that I am over 18 years of age, and that I 








Researcher’s contact details: Joanne MacLeod, Trainee Clinical Psychologist 
Psychiatric Rehabilitation Department, First Floor, Old Admin Block, Royal Cornhill Hospital, 
Aberdeen.  Telephone:  01224 557474 
 
When completed: 1 for participant; 1 for researcher site file; 1 (original) to be kept in medical notes. 
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Appendix 7: Letter to GPs informing of patient participation. 
                                                                                                                                              
 
 
Psychiatric Rehabilitation Department                         Date: 
First Floor      Enquiries to: Joanne MacLeod 
Old Admin Block     Telephone: 01224 557474 





Dear Dr <<<insert GP name>>> 
 
 
I am writing to inform you that <<<insert patient name>>> is taking part 
in a research project investigating the benefits of cognitive remediation 
in schizophrenia. 
 
During this project cognitive functioning and performance based 
functioning will be assessed before and after a five week computer 
intervention program that aims to improve cognitive functioning.  In 
addition to this, all participants will be followed up one-month after the 
intervention to investigate whether any improvements are maintained. 
 
This project has been approved by the North of Scotland Ethics 
Committee. If you would like to discuss the project further please do not 


















































Variable Skewness Std.  Error Z Kurtosis Std. Error Z 
MCCB 
Speed of processing 0.100 0.434 
 
0.230 0.096 0.845 
 
0.114 
Attention/vigilance -0.272 0.434 -0.627 -0.675 0.845 -0.799 
Working memory -0.308 0.434 -0.710 -0.489 0.845 -0.579 
Visual learning 0.375 0.434 0.864 -1.042 0.845 -1.233 
Verbal learning 0.328 0.434 0.756 -0.814 0.845 -0.963 
Reasoning/problem solving 1.023 0.434 2.357 0.919 0.845 1.088 















Social Functioning Scale 
SFS W 0.774 0.434 
 
1.783 1.347 0.845 
 
1.594 
SFS IP -1.163 0.434 -2.680 1.220 0.845 1.444 




Variable Skewness Std.  Error Z Kurtosis Std. 
Error 
Z 
MCCB       
Speed of processing -0.725 0.472 -1.535 0.597 0.918 0.650 
Attention/vigilance -0.524 0.491 -1.066 -0.660 0.953 -0.693 
Working memory -0.517 0.472 -1.094 -0.373 0.918 -0.407 
Visual learning 0.652 0.472 1.380 -0.462 0.918 -0.503 
Verbal learning 0.809 0.472 1.713 0.063 0.918 0.069 
Reasonong/problem solving 0.283 0.472 0.600 -1.030 0.918 -1.122 
Social cognition 0.213 0.472 0.452 -0.169 0.918 -0.184 
UPSA-BRIEF   
Total score -0.031 0.464 
 
-0.067 -1.053 0.902 
 
-1.167 














SFS IP -1.562 0.464 -3.368 1.836 0.902 2.036 












Variable Skewness Std.  Error Z Kurtosis Std. 
Error 
Z 
MCCB       
Speed of processing -.136 .491 -0.278 .098 .953 0.102 
Attention/vigilance -.203 .491 -0.414 .226 .953 0.237 
Working memory -.982 .491 -1.999 .172 .953 0.181 
Visual learning .581 .501 1.159 -.693 .972 -0.712 
Verbal learning .094 .491 0.191 -.646 .953 -0.678 
Reasonong/problem solving .118 .491 0.240 -1.009 .953 -1.059 















Social Functioning Scale       
SFS W .155 .464 0.334 .082 .902 0.091 
SFS IP -1.562 .464 -3.368 1.836 1.836 1.000 






Variable Skewness Std.  Error Z Kurtosis Std. 
Error 
Z 
MCCB    
 
   
Speed of processing .341 .550 0.620 -.124 1.063 -0.117 
Attention/vigilance -.445 .564 -0.789 -.899 1.091 -0.824 
Working memory -.672 .550 -1.222 -.173 1.063 -0.163 
Visual learning .530 .564 0.940 -.817 1.091 -0.749 
Verbal learning .084 .550 0.153 -1.067 1.063 -1.004 
Reasonong/problem solving .413 .550 0.751 -.661 1.063 -0.622 















Social Functioning Scale       
SFS W .944 .536 1.761 .489 1.038 0.471 
SFS IP -.777 .536 -1.450 -.093 1.038 -0.090 

























































































Appendix 11: Post hoc pairwise comparison tables 
 
Table 1: speed of processing  
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -3.941 1.405 .076 -8.168 .286 
3 -5.647
*
 1.328 .004 -9.643 -1.651 
4 -6.412
*
 1.430 .002 -10.713 -2.110 
2 1 3.941 1.405 .076 -.286 8.168 
3 -1.706 1.487 1.000 -6.180 2.768 
4 -2.471 1.453 .650 -6.842 1.900 
3 1 5.647
*
 1.328 .004 1.651 9.643 
2 1.706 1.487 1.000 -2.768 6.180 
4 -.765 1.059 1.000 -3.951 2.421 
4 1 6.412
*
 1.430 .002 2.110 10.713 
2 2.471 1.453 .650 -1.900 6.842 
3 .765 1.059 1.000 -2.421 3.951 
Based on estimated marginal means 
a. Adjustment for multiple comparisons: Bonferroni. 
*. The mean difference is significant at the .05 level. 
 
Table 2: visual learning 
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 .500 1.586 1.000 -4.317 5.317 
3 -.375 2.097 1.000 -6.743 5.993 
4 -5.188 1.887 .089 -10.916 .541 
2 1 -.500 1.586 1.000 -5.317 4.317 
3 -.875 2.536 1.000 -8.576 6.826 
4 -5.688 2.091 .095 -12.037 .662 
3 1 .375 2.097 1.000 -5.993 6.743 
2 .875 2.536 1.000 -6.826 8.576 
4 -4.813 2.619 .516 -12.765 3.140 
4 1 5.188 1.887 .089 -.541 10.916 
2 5.688 2.091 .095 -.662 12.037 









Table 3: reasoning/problem solving 
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -3.824 1.332 .067 -7.830 .183 
3 -6.118
*
 1.150 .000 -9.577 -2.658 
4 -6.059
*
 1.282 .001 -9.915 -2.203 
2 1 3.824 1.332 .067 -.183 7.830 
3 -2.294 1.495 .866 -6.790 2.202 
4 -2.235 1.335 .682 -6.253 1.782 
3 1 6.118
*
 1.150 .000 2.658 9.577 
2 2.294 1.495 .866 -2.202 6.790 
4 .059 1.290 1.000 -3.823 3.941 
4 1 6.059
*
 1.282 .001 2.203 9.915 
2 2.235 1.335 .682 -1.782 6.253 
3 -.059 1.290 1.000 -3.941 3.823 
Based on estimated marginal means 
a. Adjustment for multiple comparisons: Bonferroni. 
*. The mean difference is significant at the .05 level. 
 
Table 4: Composite score 
(I) time (J) time 
Mean 
Difference (I-J) Std. Error Sig.
a
 




Lower Bound Upper Bound 
1 2 -2.000 1.267 .857 -6.066 2.066 
3 -4.500
*
 1.184 .018 -8.298 -.702 
4 -6.333
*
 1.378 .005 -10.754 -1.912 
2 1 2.000 1.267 .857 -2.066 6.066 
3 -2.500 1.717 1.000 -8.007 3.007 
4 -4.333
*
 1.333 .046 -8.611 -.056 
3 1 4.500
*
 1.184 .018 .702 8.298 
2 2.500 1.717 1.000 -3.007 8.007 
4 -1.833 1.308 1.000 -6.028 2.361 
4 1 6.333
*
 1.378 .005 1.912 10.754 
2 4.333
*
 1.333 .046 .056 8.611 
3 1.833 1.308 1.000 -2.361 6.028 
Based on estimated marginal means 
a. Adjustment for multiple comparisons: Bonferroni. 
*. The mean difference is significant at the .05 level. 
 
